Cumulative Live Birth Rates after In Vitro Fertilization by Olivius, Catharina
  
 
 
 
Cumulative Live Birth Rates after In Vitro 
Fertilization 
 
Catharina Olivius 
 
 
 
 
 
 
 
 
 
 
2009 
 
 
Department of Obstetrics and Gynaecology 
Institute of Clinical Sciences 
Sahlgrenska Academy, University of Gothenburg 
Göteborg, Sweden  
Front cover: “Sperm & Egg”, design by James Steidl. Purchased at www.istockphoto.com. 
ISBN: 978-91-628-7914-3
Triumf att leva, triumf att andas, triumf att finnas till! 
Triumf att känna tiden iskall rinna genom sina ådror 
och höra nattens tysta flod 
och stå på berget under solen. 
…
Solen fyller upp mitt bröst med ljuvlig honung upp till
randen
och hon säger: en gång slockna alla stjärnor, men de lysa
alltid utan skräck. 
(Ur Triumf att finnas till, Edith Södergran 1916) 
A triumph to live, a triumph to breathe, a triumph to exist! 
A triumph to feel time run icy cold through your veins 
and hear the silent river of night 
and stand on the mountains under the sun. 
…
The sun fills up my breast up to the brim with sweet
honey
and she says: one day all stars will die, but they always
shine fearlessly. 
(From A triumph to exist, Edith Södergran 1916, translation by Martin Allwood) 

Abstract
Background: In vitro fertilization (IVF) has become increasingly common, today representing 
about 3% of all live births in some countries. Most patients have to undergo more than one treatment 
in order to achieve a live birth. Thus cumulative live birth rates are highly interesting to the patients. 
The most important health problem in IVF is the high rate of multiple births, leading to increased risks 
for preterm birth and perinatal morbidity. Therefore, single embryo transfer (SET) has become more 
frequently used.  
Aims: The aims of this thesis were to assess cumulative live birth rates after IVF and to investigate 
factors affecting the live birth rates. 
Methods: Paper I: Cumulative live birth rates after a treatment programme consisting of three 
fresh IVF cycles and subsequent frozen-thawed cycles were investigated in 974 patients. Life table 
analysis with and without taking dropouts into account gave three estimates; "pessimistic", "realistic" 
and "optimistic". Paper II: Many of the patients in Paper I discontinued the treatment. The reasons for 
this were investigated in Paper II, by scrutinizing medical records and using questionnaires. Paper III:
Maternal and embryonic factors were analyzed in 371 patients for possible prediction of live birth in 
frozen-thawed SET, using multiple logistic regression. Paper IV: A follow up of a previous 
randomized controlled trial (RCT), comparing single and double embryo transfer (DET) in 661 
patients. Data on all additional frozen-thawed cycles were collected in order to present cumulative live 
birth rates.
Results: Paper I: The cumulative live birth rate after three fresh IVF cycles, mostly DETs, 
including subsequent frozen-thawed cycles was 63% with a “realistic” approach. Paper II: Of the 
couples in Paper I who did not achieve a live birth, 54% discontinued the treatment programme. The 
most important reasons were psychological stress and poor prognosis. The most frequent comment 
was “needed more information about the treatment”. Paper III: Positive predictors for live birth in 
frozen-thawed SET were blastomere survival rate, number of previous fresh cycles and conventional 
IVF as compared with intracytoplasmic sperm injection (ICSI). Number of embryos needing to be 
thawed in order to perform one transfer was negatively associated with pregnancy. Paper IV: The 
cumulative live birth rates after one fresh SET or DET and subsequent frozen-thawed cycles, with one 
or two embryos transferred according to the patient’s wish, were 44% in the SET group and 51% in 
the DET group (p=0.08). The multiple birth rates were 2% in the SET group and 28% in the DET 
group (p<0.001).  
Conclusions: There is a good chance of achieving a live birth through a treatment programme of 
three IVF cycles. Implementation of SET is an effective way to decrease multiple birth rates. The 
cumulative live birth rate after one SET, including frozen-thawed transfers, was not significantly lower 
than after DET. The frozen-thawed cycles contribute significantly to the cumulative live births, and 
the knowledge of predictive factors for live birth in frozen-thawed cycles is valuable when deciding 
whether to perform SET or DET. The dropout rate from the treatment programme was high. The 
knowledge that many patients perceive IVF treatment as psychologically stressful and feel a need of 
more information can be useful in patient consultations and when organizing the care at the IVF 
clinics.
Key words: In vitro fertilization, cumulative live birth, single embryo transfer, frozen-thawed cycle, 
discontinuation  
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Sammanfattning på svenska 
Provrörsbefruktning (in vitro fertilization, IVF) ger upphov till omkring 3% av alla födslar 
i Sverige idag. De flesta patienter behöver genomgå mer än en IVF-behandling för att få barn. 
Kumulativa födelsetal, dvs andelen par som får barn efter ett antal behandlingscykler, är 
därför av stort intresse för patienterna. Det största hälsoproblemet med IVF är den höga 
flerbördsfrekvensen. Flerbörd är förknippat med ökad risk för förtidig födsel och 
komplikationer för barnen. För att minska flerbördsfrekvensen tillämpas i allt större 
utsträckning återförande av endast ett befruktat ägg per behandling (single embryo transfer, 
SET).
Artikel I: Kumulativa födelsetal analyserades i en grupp av 974 IVF-patienter. 
Sannolikheten för att få barn efter det behandlingsprogram som erbjuds i regionens regi om 
tre färska IVF-cykler med efterföljande fryscykler var 63%. Sannolikheten var högre för 
kvinnor under 35 år (67%) än för kvinnor 35-40 år (52.5%), men det var ingen skillnad för 
patienter med olika infertilitetsdiagnoser.   
Artikel II: Skälen till varför 54% av de patienter som inte fick barn i Artikel I hade 
avbrutit behandlingsprogrammet i förtid undersöktes genom journalstudier och enkäter. De 
vanligast förekommande skälen var psykisk stress och dålig prognos.
Artikel III: Faktorer förknippade med födsel vid återförande av frysta och tinade 
befruktade ägg undersöktes hos 371 kvinnor. Cellöverlevnaden hos det tinade befruktade 
ägget, antalet färska behandlingscykler patienten hade genomgått, och standard-IVF som 
befruktningsmetod jämfört med mikroinjicering av spermien i ägget (intracytoplasmic sperm 
injection, ICSI) var faktorer förknippade med en ökad chans till födsel. Antalet befruktade 
ägg som behövde tinas för att åstadkomma ett äggåterförande var förknippat med minskad 
chans till graviditet. 
Artikel IV: Uppföljning gjordes av en tidigare studie där 661 patienter genom 
slumpmässig tilldelning genomgått antingen SET eller återförande av två befruktade ägg 
(double embryo transfer, DET). Kumulativ födelsefrekvens efter färsk SET eller DET 
inklusive efterföljande fryscykler, i vilka ett eller två befruktade ägg hade återförts oberoende 
av den inledande slumpningen, var 44% i SET-gruppen och 51% i DET-gruppen (ej statistiskt 
signifikant skillnad). Flerbördsfrekvensen var 2% i SET-gruppen och 28% i DET-gruppen. 
Slutsats: Sannolikheten är god att få barn efter tre IVF-behandlingar. SET är en effektiv 
metod för att minska flerbördsfrekvensen vid IVF. Kumulativa födelsetal efter SET med 
efterföljande fryscykler var inte signifikant lägre än efter DET. Kunskapen om vilka faktorer 
som påverkar prognosen vid fryscykler är viktig när man avgör om ett eller två befruktade ägg 
ska återföras. En stor andel av patienterna som inte fick barn avbröt behandlingsprogrammet i 
förtid. Medvetenhet om att många patienter upplever IVF-behandlingen som psykiskt 
påfrestande kan vara av värde i patientkonsultationer och när man organiserar vårdens 
utförande.
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Papers I-IV
Abbreviations and definitions 
AH Assisted hatching
AIH Artificial insemination husband
ART Assisted reproductive technology, includes IVF and intrauterine insemination
CI Confidence interval
Completed cycle IVF cycle that achieved embryo transfer 
Conventional IVF Also called “standard IVF” 
DET Double embryo transfer
ESHRE European Society of Human Reproduction and Embryology
FET Frozen-thawed embryo transfer 
FSH Follicle-stimulating hormone
GEE Generalized estimation equation 
GnRH Gonadotropin-releasing hormone
GQE Good quality embryos
hCG Human chorionic gonadotropin
hMG Human menopausal gonadotropin
ICMART International Committee for Monitoring Assisted Reproductive Technology
ICSI Intracytoplasmic sperm injection
IVF In vitro fertilization. Refers to the entire treatment. Includes both cycles with
fertilization with standard IVF and with ICSI 
LH Luteinizing hormone
Low birth weight <2500 g 
OHSS Ovarian hyperstimulation syndrome
Optimistic estimate Cumulative live birth rate estimate where all patient dropouts are given the
same chance of a live birth as the continuers (standard life table analysis)
Pessimistic estimate Cumulative live birth rate estimate where all patient dropouts were given no
chance of live birth (i.e. real, observed rate) 
PGD Preimplantation genetic diagnosis
PGS Preimplantation genetic screening 
Preterm birth <37 gestational weeks 
RCT Randomized controlled trial
Realistic estimate Cumulative live birth rate estimate; the patients who dropped out owing to
poor prognosis were given no chance of a live birth, while the other dropouts 
were given the same chance as the continuers (modified life table analysis)
SET Single embryo transfer
SD Standard deviation
Started cycle IVF cycle where ovarian stimulation was initiated
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Introduction
Historical background of assisted 
reproduction
The mechanism of reproduction has 
historically been a matter of great interest.
An important step away from superstition 
and folklore beliefs took place when one of 
the first microscopists, Leeuwenhoek (1632-
1723), made the first observations of human
spermatozoa. The scientists initially
believed that the spermatozoa were 
parasites, hence the ending -zoa. A widely 
discussed theory was that a homunculus, a 
miniature human, was encapsulated in the 
sperm head, ready for implantation in the
female uterus.
The first example of assisted
reproductive technology (ART) was when 
the Italian scientist Spallanzani successfully
inseminated a spaniel bitch in 1783. In 
1827, von Baer and van Beneden made the
first observation of a mammalian oocyte. 
Human artificial insemination was intro-
duced in 1838 by Dr Girault in France, but 
acceptance amongst the medical
establishment took a long time, and artificial 
insemination remained controversial in
many countries until mid twentieth century 
(Clarke, 2006). From the late nineteenth
century, several scientists made attempts to 
fertilize both human and animal oocytes in 
vitro but without success (Schenk, 1878; 
Pincus and Enzmann, 1935). It was not until 
the discovery by Austin and Chang in 1951 
of sperm capacitation, a sperm maturation
process that occurs after entrance into the
female reproductive tract and is necessary
for penetration into the egg, that fertilization 
in vitro succeeded (Austin, 1952).  Rabbit 
oocytes were fertilized in vitro in 1954 
(Dauzier et al., 1954), and in 1959 the first 
in vitro fertilization leading to a live birth 
was achieved, in a rabbit (Chang 1959). The 
first evidence of fertilization of a human
oocyte in vitro was seen in 1969 (Edwards 
et al., 1969), but it took years before the IVF 
technology led to a human live birth. 
The first human IVF resulting in a live 
birth took place in 1978 (Steptoe and
Edwards, 1978). During the early 1980s, the 
cryopreservation techniques for in vitro 
fertilized oocytes were developed, resulting 
in the first pregnancy after a frozen-thawed 
embryo transfer in 1983 (Trounson and 
Mohr, 1983). Intracytoplasmic sperm
injection (ICSI) has been an important 
addition to the treatment arsenal of male
infertility since 1992, when the first human
live birth after ICSI was achieved (Palermo
et al., 1992). IVF has increased steadily as a 
treatment for infertility since its beginnings
in 1978, and has until today resulted in 
about 4 million live births (personal 
communication 2009, Karl Nygren, 
ICMART Chair).
Infertility and ART today 
Infertility is defined by the World Health 
Organization as failure to become pregnant 
after one year of unprotected intercourse, 
and affects 10-15% of couples of 
reproductive age. The causes of infertility 
are female in approximately one third, male
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in one third, and multifactorial or
unexplained in one third. Causes of female
infertility include tubal pathology, poly-
cystic ovary syndrome, other ovulatory 
dysfunction, diminished ovarian reserves, 
endometriosis, and uterine factors. Male 
infertility is attributable to poor sperm 
quality, mainly idiopathic oligozoospermia,
astenozoospermia or teratozoospermia. The 
poor sperm quality is often idiopathic, but in 
come cases infections, chromosomal
abnormalities, systemic diseases and 
hormonal disorders are underlying causes 
(Irvine, 1998).
ART includes IVF and intrauterine 
insemination. IVF includes cycles with
fertilization using standard IVF or ICSI,
using own eggs or donor eggs, own sperm 
or donor sperm, in fresh cycles and frozen-
thawed cycles. Table 1 shows the quantity 
of ART treatments in Europe in 2005. The 
European countries perform the largest 
number of IVF treatments followed by the 
USA. In 2002 241,000 cycles reaching egg 
aspiration were performed in Europe, 
74,000 in the USA, 45,000 in Asia, 29,000 
in the Middle East, 18,000 in New 
Zeeland/Australia and 20,000 in other 
countries (ICMART, 2009). In 2005, IVF 
treatment represented 2-4% of all live births 
in the European countries and 2.9% of all 
live births in Sweden (Nyboe Andersen et 
al., 2009).
Sperm donation has, during the last two 
decades, been available for couples with
severe male infertility, used by insemination
or by IVF. Sperm donation is in some
countries also offered to lesbian couples and 
single women. Oocyte donation, where the 
donor’s oocytes are fertilized in vitro with 
sperm from the partner of the recipient, after 
which the embryos are transferred to the
female recipient, has become an alternative 
for couples where the woman has poor 
oocyte quality or poor oocyte reserves. In 
Sweden oocyte donation is only permitted
for women of reproductive age, while in 
some other countries it is also available for 
women with normal age-related infertility.
Gestational surrogacy is an option where,
after fertilization in vitro, embryos are
transferred to a gestational carrier.
Gestational surrogacy was developed 
primarily for women with good egg quality 
but uterine pathology. It is also available for
male homosexuals in some countries. In 
cancer patients, cryopreservation of sperm 
for later use in IVF is a successful method,
while cryopreservation of oocytes or ovarian 
tissue is still under development.
 
 
Table 1. ART treatments performed in Europe in 2005 (Nyboe Andersen et al., 2009) 
No. of cycles 
 
 
Fresh standard IVF cycles 118.074 
 
Fresh ICSI cycles 203.329 
 
Frozen-thawed cycles (IVF and ICSI) 79.140 
 
Oocyte donation cycles 11.475 
 
Intrauterine insemination (husband) 128.908 
 
Intrauterine insemination (donor) 20.568 
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The legislation concerning ART differs
greatly between different countries. Some
countries have hardly any legislation at all, 
while others have very strict rules. The
legislations of many European countries are 
documented at www.eshre.com. The 
Swedish legislation and guidelines include 
crude age restrictions, restrictions on egg 
and sperm donation, assessment of social 
factors and rules for infection screening. For 
example, anonymous gamete donation is not 
allowed; each child has the right to know 
his/her genetic origin after having reached
maturity. The woman should not have 
reached the age when fertility is normally in 
sharp decline when IVF with donated eggs 
is initiated. The guidelines from 2003 also 
declare that only one embryo should 
normally be transferred. Two embryos
might, however, be transferred when the risk
of a twin pregnancy is considered limited.
Lesbian couples are offered IVF with donor
sperm. In Sweden, treatment of single 
women with sperm donation or of male
homosexual couples with gestational 
surrogacy is currently not allowed. 
According to the local rules at
Sahlgrenska University Hospital, the treated
woman must not be over 40 years of age and 
her partner under 55 years of age when the 
IVF treatment is initiated, and the couple 
must have a stable relationship, defined as 
being married or having lived together for at 
least two years. Drug abuse, severe 
criminality, life threatening disease or
psychiatric or social circumstances that 
make it impossible to take care of a child,
are considered as relative or absolute contra-
indications for IVF.
IVF procedures
IVF can be performed either in natural 
cycles or in hormonally stimulated cycles.
Natural cycle IVF was abandoned early 
owing to much lower pregnancy rates, but 
has been discussed again lately in 
accordance with the trend of transferring
fewer embryos and using milder stimulation 
(Nargund and Frydman, 2007). In 
hormonally stimulated IVF cycles, down-
regulation of the pituitary gonadal axis is 
commonly performed by nasal administra-
tion of a gonadotropin-releasing hormone
(GnRH) agonist for 2-4 weeks (Figure 1).
Figure 1. Example of a hormone stimulation protocol using GnRH agonist.  
hCG  
(Subcutaneous 
injection once, 
36h before egg 
retrieval) 
GnRH-agonist  
(Nasal spray daily, 2-4 
weeks before FSH/hMG 
and until hCG) 
Egg 
aspiration 
Embryo 
transfer 
FSH/hMG  
(Subcutaneous 
injections daily, 
9-12 days) 
Progesterone  
(Luteal support  
vaginally. Until neg 
pregnancy test or 
2w after pos 
pregnancy test)  
Stimulation is monitored by vaginal 
ultrasound and serum-estradiol levels. 
Stimulation is complete and hCG 
administered when ?2 follicles are >17 mm.
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A shorter protocol using a GnRH antagonist 
is also possible. Ovarian stimulation is 
initiated by daily subcutaneous injections of
follicle-stimulating hormone (FSH) or 
human menopausal gonadotropin (hMG), 
and monitored by serum-estradiol levels and 
vaginal ultrasound. The stimulation is 
complete when at least two ovarian follicles
measures >17 mm, and human chorionic
gonadotrophin (hCG) is injected for final 
oocyte maturation. The oocytes are aspirated 
36 h after the hCG injection, using
transvaginal ultrasonographically guided 
puncture, usually with conscious sedation in 
combination with local anesthetics.
Fertilization is performed using
conventional IVF or intracytoplasmic sperm 
injection (ICSI; Figure 2 and 3). The
embryos are examined daily and graded by 
degree of fragmentation, number of cells, 
cell size and presence of multinucleation.
Embryos are transferred either in the 
cleavage stage, on day 2-3, or in the 
blastocyst stage, on day 5-6. Embryo
transfer is performed by depositing the 
embryo in the uterus through a catheter, 
guided by abdominal ultrasound.
Since about ten oocytes are aspirated in 
an average IVF cycle and only one or two 
embryos are transferred, there are often 
supernumerary embryos available for
freezing. In cryopreservation, the embryos
are exposed to a cryoprotectant agent, e.g.
1,2-propanediol, which replaces the
intracellular water and reduces the 
intracellular formation of ice crystals. In the 
traditional cryopreservation technique called 
“slow freezing”, the embryos are slowly 
cooled to around -100°C before transfer to 
and storage in liquid nitrogen in -196°C. A 
new ultra-rapid freezing technique called 
“vitrification” that may have some
advantages over slow freezing,  has  recently
Figure 2. Conventional (“standard”) IVF. 
The oocyte is placed in a nutritional 
solution containing a fixed concentration 
of sperm, allowing the sperm to penetrate 
and fertilize the egg. 
 
 
Figure 3. ICSI. One sperm is injected into 
a mature oocyte by use of a micropipette. 
 
been introduced. Frozen-thawed cycles are 
performed in either natural menstrual cycles
or, for anovulatory patients, hormone
stimulated cycles, usually with oral estrogen 
and vaginal progesterone.
Ovarian hyperstimulation syndrome
(OHSS) is the most serious complication for 
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the woman in IVF. OHSS is an iatrogenic
condition with enlarged ovaries, abdominal
pain, ascites, nausea, and can, in severe
cases, be life threatening with pleural
effusion, multiple organ failure and
disseminated intravascular coagulation. 
High estradiol levels and a high number of 
large follicles are known risk factors for 
developing OHSS (Delvigne et al., 2002, 
Kahnberg et al., 2009). Possible actions to 
prevent OHSS in patients at risk include 
reduction of FSH dosages during 
stimulation, “coasting” of cycles, i.e.
stopping the gonadotropin administration
and delaying hCG until estradiol levels
decrease, and cryopreservation of all
embryos instead of fresh embryo transfer 
(Delvigne et al., 2002). Other complications
in IVF such as bleeding and infections are 
rare. Apart from the immediate medical
complications associated with treatment, the 
high incidence of multiple births is
considered the main adverse outcome in IVF 
(Bergh et al., 1999). 
Live birth rates after IVF
Live birth rates after IVF have improved
steadily over the years. The most recent live
birth rates are listed below (Table 2). The 
live birth rates per embryo transfer are 
higher in the USA than in Sweden and
Europe (Table 2). This can at least partly be 
explained by the higher number of embryos
per transfer, also reflected in the fact that 
there are more multiple births in the USA 
than in Europe. When calculating the live 
birth rate per embryo transferred this was, 
however, shown to be higher in Sweden 
than in the USA during 1995-2003 
(Karlström and Bergh 2007). The most
important factor influencing the multiple 
birth rate is the number of embryos
transferred. Worldwide, there has been a 
steady decrease in the number of embryos
transferred per cycle; however most embryo
transfers still take place with two or more
embryos in most countries. The highest rates 
of single embryo transfer (SET) are in the
Scandinavian countries, Belgium, Holland 
and Australia/New Zeeland (ICMART 
2009).
The live birth rates after ICSI are slightly
lower than after conventional IVF (Table 2). 
This is probably attributable to the fact that
ICSI is used not only for male factor 
infertility but also in cases of poor 
fertilization, which is a poor prognostic 
factor; ICSI for male infertility has similar
live birth rates as other diagnostic subgroups 
(Lintsen et al., 2007).
The live birth rates after frozen-thawed
cycles are lower than after fresh cycles
(Table 2). However, frozen-thawed cycles
are an important complement to the fresh 
cycles and contribute to a considerable share 
of the live births after IVF: 23.7% in 
Sweden, 15.0% in Europe, and 16.3% in the 
USA in 2005 (The Swedish National Board
of Health and Welfare 2008, Nyboe 
Andersen et al., 2009, Wright et al., 2008). 
Frozen-thawed cycles have some
advantages, as they are safer, cheaper and 
more comfortable for the woman, as
compared with fresh cycles.
Transfer of blastocysts (cultured to day 
5/6) has shown superior live birth rates as 
compared with cleavage stage embryos
(cultured to day 2/3), and in a Cochrane
systematic review the live birth rate per 
couple was 36.0% with blastocysts and 
29.4% with cleavage stage embryos (Blake 
et al., 2007). However, there are some
disadvantages with blastocyst transfer: it is a 
more expensive culturing technique, a 
greater risk of failure of transferring any 
embryos at all in a particular cycle, and
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Table 2. Live birth rates, number of embryos transferred and multiple birth rates in 2005.
 
 
 Sweden Europe¤ USA*
 
 
Live birth rate per embryo transfer (%)  
  -Fresh, total 25.5 19.4 34.3  
  -Fresh IVF 27.0 21.3 - 
  -Fresh ICSI 23.8 18.4 - 
  -Frozen-thawed 18.6 13.5 28.0 
 
Number of embryos transferred (% of fresh transfers)  
  -One 69.4 20.0 7.0 
  -Two 30.6 56.1 58.8 
  -Three 0 21.5 26.7 
  -Four or more 0 2.3 7.6 
 
Multiple birth rate (%) 6.7 21.8 30.5
   
 (The Swedish National Board of Health and Welfare, Nyboe Andersen et al., 2009, Wright et al., 2008). 
¤Including Sweden.  
*Results according to fertilization method (IVF/ICSI) were not accessible. The number of embryos transferred    
refers only to women below 35.  
yields fewer embryos available for freezing
(Blake et al., 2007). In addition, the survival 
of embryos after cryopreservation of 
blastocysts has not been as good as for 
cleavage stage embryos, but with the 
introduction of vitrification that might
change (Loutradi et al., 2008). 
Factors affecting the live birth rates 
The woman’s age is the most important
factor influencing the live birth rate. The 
chances of a live birth after IVF begin to
decline after the age of 35, and the decline is 
substantial after 40 (Wright et al., 2008, The
Swedish National Board of Health and 
Welfare 2009, Templeton et al., 1996). 
Somewhat surprisingly the live birth rates 
were slightly lower in women under 25 in 
two large studies (Templeton et al., 1996, 
Lintsen et al., 2007). This is contradicted by 
the most recent Swedish data where the live
birth rates are similar for women under 25 
as for women 25-34 years of age (The 
Swedish National Board of Health and
Welfare 2009). 
The live birth rates for couples with 
different reasons for infertility do not differ 
to any major extent (Templeton et al., 1996, 
Stolwijk et al., 2000, Lintsen et al., 2007). 
Unexplained infertility has a slightly better
prognosis (Omland et al., 2005), and tubal 
pathology and endometriosis have slightly 
poorer prognoses in some publications 
(Omland et al., 2005, Wright et al., 2008). 
Since there is a rather high rate of 
spontaneous pregnancy in couples with 
unexplained infertility up to three years 
before it levels off, these couples are in 
many countries advised to wait for up to 
three years before starting IVF treatment
(Pandian et al., 2005). In a Dutch study on 
patients on waiting lists for IVF it was found 
that 9.1% of the couples achieved a 
spontaneous ongoing pregnancy within a 
year. The chances of a spontaneous 
pregnancy were higher for couples where 
the woman was relatively younger, had 
shorter duration of infertility, secondary 
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compared with primary infertility, and for
couples with unexplained, male or immuno-
logical reasons for infertility (Eijkemans et 
al., 2008). 
Longer duration of infertility has been 
shown to negatively affect live birth rates, as 
well as the number of previous failed IVF 
cycles (Templeton et al., 1996, Lintsen et 
al., 2007). Previous pregnancy and live birth 
are positive predictors for ongoing 
pregnancy and live birth (Templeton et al., 
1996, Stolwijk et al., 2000). Overweight 
(BMI>30) was found to have a negative 
effect on the live birth rate (Fedorcsak et al.,
2004). In a study from our own centre it was 
shown that undergoing the first IVF cycle, 
IVF as fertilization method as compared 
with ICSI, transfer of a 4-cell embryo and 
ovarian sensitivity correlated independently
to ongoing implantation (Thurin et al., 
2005).
The question as to whether anxiety and
depression can cause infertility or lower the 
chances of a live birth has been investigated
in many studies, and conflicting data have 
been presented. In a recent Dutch study 
(Lintsen et al., 2009) of 783 patients, the 
level of anxiety and depression showed no 
association to the chance of a pregnancy, or 
to the drop-out rate. Other studies with
fewer patients have shown significant
correlations between stress, anxiety and 
lower pregnancy rates after IVF (Klonoff-
Cohen et al., 2001, Smeenk et al., 2001). 
Somewhat surprising results were shown in 
another study, in which the women who 
were more negative before treatment had a
greater chance of a pregnancy than those 
who were less negative (de Klerk et al.,
2008).
In frozen-thawed cycles, blastomere
survival rate after thawing has been shown 
to be positively associated with pregnancy 
(Salumets et al., 2006; Tang et al., 2006; 
Edgar et al., 2007). Pregnancy in fresh 
IVF/ICSI cycle from which the frozen
embryos originated (El-Toukhy et al., 2003; 
Urman et al., 2007), and the number of 
embryos transferred have also been shown 
to be predictive factors for pregnancy in 
frozen-thawed cycles (Lahav-Baratz et al., 
2003; Salumets et al., 2006; Edgar et al., 
2007).
Cumulative live birth rates
When an infertile couple presents at the 
IVF clinic, their most important question is
how great their chances are of having a child 
after the treatment, the “take home baby-
rate”. Cumulative live birth rates answer the 
question of the probability of live birth after 
a series of fresh IVF cycles with or without 
subsequent frozen-thawed cycles, or after 
one fresh cycle including its subsequent 
frozen-thawed embryo transfers. The
usually provided statistics presented at a 
national level or by separate clinics are live
birth rates per cycle (The Swedish National 
Board of Health and Welfare 2008, Nyboe 
Andersen et al., 2009, Wright et al., 2008). 
Cumulative live birth rates are more
complex to analyze. Cumulative live birth 
rates are affected by, in addition to the 
factors affecting the live birth rates per cycle 
mentioned above, the patient dropout rate, 
the utilization of surplus cryopreserved 
embryos, and the decline in live birth rate 
with each failed cycle. The pioneer in
calculating cumulative success rates after 
IVF was Dr HW Jones, who used a 
parametric statistical model and presented
cumulative pregnancy rates in 1986 (Guzick 
et al., 1986).
The statistical method most frequently 
used when calculating cumulative live birth
rates is the life table analysis, also called the
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Figure 4. Malizia et al., 2009. Cumulative live birth rates after in-vitro fertilization. 
“Optimistic” (life table analysis) and “conservative” (observed) cumulative live birth rates 
among 6,164 women. (Published with permission from N Engl J Med). 
Kaplan-Meier Curve. Since all patients who 
drop out of treatment are assumed to 
have the same probability  of  live  birth  as  
women who continue in life table analysis, 
this method tends to overestimate the live 
birth rates (Stolwijk et al., 1996., Land et al., 
1997). Thus, to compensate for the 
overestimation, a modified life table 
analysis has been introduced producing one
”pessimistic”, one “optimistic” and one
“realistic” estimate that differ in terms of the 
way the drop-out group is dealt with 
(Stolwijk et al., 1996, see Methodological 
considerations, statistics).
A former study of cumulative live birth 
rates performed at our centre included 398 
couples undergoing IVF treatment during 
1990-1992. The cumulative live birth rate 
was 50.0% after three available IVF cycles 
(“conservative estimate”, Bergh et al.,
1995). A recent large American study 
presented “optimistic” and “conservative” 
cumulative live birth rates as illustrated in
Figure 4 (Malizia et al., 2009). 
Outcome in children born following
IVF
Numerous publications have reported 
increased risks for perinatal mortality,
preterm birth, low birth weight, congenital 
malformations and neurological complic-
ations for IVF children as compared with
children born after spontaneous conception 
(Bergh et al., 1999; Strömberg et al., 2002; 
Helmerhorst et al., 2004; Jackson et al., 
2004). Most of the increased risks can be 
explained by the high multiple birth rate
(Nygren et al 2007). However, even for IVF
singletons as compared with spontaneously 
conceived singletons, and for IVF twins as 
compared with spontaneously conceived 
twins of unlike sex, an increased risk for 
preterm birth and low birth weight has been 
found (Bergh et al., 1999, Nygren et al., 
2007, Hansen et al., 2009). The risk 
decreases to a large extent when adjusting
for parental characteristics, including their 
subfertility status, but remains significant
(Bergh et al., 1999, Nygren et al., 2007). 
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Cross-linkage between the Swedish IVF 
registry and other population-based 
registries in Sweden has been performed on 
three occasions. In the first report from these 
cross-linkages, which compared almost
6,000 IVF children with 1,500,000 
spontaneously conceived children, the rates 
in IVF children versus spontaneously 
conceived children for preterm birth were 
30.3% and 6.3%, low gestational weight 
27.4% and 4.6% and perinatal mortality 
1.9% and 1% respectively. Most of the 
higher risk for the IVF children could be 
explained by multiple births (Bergh et al.,
1999).
The risk of neurological complications
was investigated in a Swedish cohort study, 
where the IVF children were found to have 
OR 3.7 (2.0-6.6) for cerebral palsy as 
compared with matched controls, and a 
four-fold higher risk for suspected develop-
mental delay. The risk elevation was mainly
attributable to the increased incidence of 
preterm birth and multiple births (Strömberg
et al., 2002). A recent Dutch meta-analysis
found no evidence of increased risk of
mental retardation and cerebral palsy from 
the IVF/ICSI treatment per se, and the 
higher risk for neurological complications
could be completely explained by the 
preterm birth rate and other risk factors 
associated with IVF. However, there is
limited research on these children beyond 
pre-school age (Middelburg et al., 2008). 
Concerning congenital malformations,
controlled studies and meta-analyses have 
shown a slight increase in malformation
rates among IVF/ICSI children as compared
with children born after spontaneous 
conception (Rimm et al., 2004; Hansen et 
al., 2005; Mc Donald et al., 2005). In the 
Swedish registry study including 16,000 
IVF children, which differs from the other 
studies in that it is the only one that adjusted 
for years of childlessness, the crude OR for 
congenital malformations among infants 
born after IVF as compared with all infants
was 1.42. However, when adjustments for
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Figure 5. Obstetric outcome in IVF/ICSI twins versus IVF/ICSI singletons. Results from 
original study by Pinborg et al., 2004, including 3,438 twins and 5,164 singletons. All 
differences in variables between singletons and twins were significant. 
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maternal age, parity, plurality and years of 
childlessness were made, the OR decreased 
below 1.0 and was no longer significant. 
(Källen et al., 2005a).
No increase in childhood cancer has been 
found (Bergh et al., 1999; Källen et al., 
2005b).
Outcome in multiple births
The increased perinatal risks for IVF 
twins as compared with IVF singletons are 
illustrated in Figure 5. Maternal risks
associated with multiple gestations include
placental abruption, pre-eclampsia and 
eclampsia, antenatal venous thrombo-
embolism and postpartum haemorrhage
(Campbell and Templeton, 2003). In early 
comparisons of IVF twins with spontane-
ously conceived twins, IVF twins were 
found to have the same or better outcome in 
terms of preterm births and perinatal 
mortality (Scheive et al., 2002; Helmerhorst
et al., 2004). This was, however, probably 
due to the fact that the vast majority of IVF 
twins, unlike the spontaneously conceived 
twins, are dizygotic and have lower risks as 
a group than monozygotic twins. In later 
studies, IVF twins have instead been 
compared with spontaneously conceived 
twins of unlike sex to avoid using mono-
zygotic twins as controls. In those studies, 
IVF twins were found to have increased 
risks for preterm birth, low birth weight and 
perinatal mortality as compared with 
controls (Pinborg et al., 2004; Hansen et al., 
2009).
Outcome in singleton births 
For IVF singletons too, an approximately 
two-fold higher risk has been shown for
perinatal mortality, preterm birth and low 
birth weight as compared with spontane-
ously conceived singletons (Bergh et al., 
1999; Helmerhorst et al., 2004; Jackson et 
al., 2004; Schieve et al., 2002; McGovern et 
al., 2004). The risk of cerebral palsy was 
found to be almost three times higher (OR 
2.8, 1.3-5.8) in IVF singletons as compared 
with matched spontaneously conceived 
controls, mostly owing to the increased
incidence of preterm birth and low birth 
weight among IVF singletons (Strömberg et 
al., 2002).
The increased risk of adverse events in
IVF singleton births can partly be explained 
in terms of maternal characteristics such as
maternal age and parity, as well as the 
subfertility itself (Källen et al., 2005ab).
Why the number of years of involuntary 
childlessness is a risk factor for adverse 
events is not fully understood, but after 
adjusting for years of subfertility the risk
decreases. Women on waiting list for IVF 
who have become spontaneously pregnant 
have been found to have a similar increased 
risk of preterm birth as women who become
pregnant following IVF treatment  (Basso 
and Baird, 2003). Women seeking infertility 
treatment are generally older and more often 
primiparous than spontaneously conceiving 
women. In a Swedish study the IVF patients 
were also less often smokers, had higher 
levels of education and higher BMI (Källen 
et al., 2005d). In a study of women who had 
conceived both spontaneously and after 
assisted fertilization, it was shown that birth 
weight, gestational age, small for gestational 
age, and preterm delivery did not differ 
significantly between infants born to the 
same woman (Romundstad et al., 2008). 
One study with a limited number of 
patients reported higher risks for preterm
birth and low birth weight among IVF fresh 
singletons born after fresh DET than after 
SET (De Sutter et al., 2006). Today there is 
no clear explanation for the increased risk 
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among IVF singletons for adverse obstetric 
events, but hormonal stimulation and 
embryo culture have both been discussed as 
potential risk factors. An interesting finding
is that children born after cryopreservation 
and without hormonal stimulation were 
shown to have the same or lower incidence 
of preterm birth and low birth weight as 
compared with children born after fresh 
cycles in a recent systematic review 
(Wennerholm et al., 2009). 
SET
In the last ten years, SET has been
introduced with the aim of avoiding multiple
pregnancies. The much lower multiple birth
rates after SET than DET can be seen in
Table 3. The SET rates in different countries 
are shown in Figure 6. Sweden has been one 
of the leading countries when it comes to 
reducing the number of embryos transferred 
per cycle. Historically in Sweden, triple
embryo transfer was used in a majority of 
cycles until 1993, after which DET was 
most common. Since 2003 when recommen-
dations from The Swedish National Board 
of Health and Welfare stated that SET 
should be the primary choice, a majority of
the fresh cycles have been SETs. In spite of 
this, the birth rate has remained on about the 
same level since 1993, about 26% per 
transfer, while the multiple birth rate has 
gone down from 35% in 1991 to 5% in 2004 
(Karlström and Bergh 2007). 
Several randomized controlled trials 
(RCT) comparing SET with DET have been 
performed, showing satisfactory delivery
rates after SET in good prognosis patients. 
The delivery rates are, however, signifi-
cantly higher after fresh DET than SET 
(Table 3). Importantly, the multiple birth 
rates are dramatically reduced with SET. 
The delivery rates after SET might be 
restored to similar levels as in DET when 
adding a frozen-thawed cycle to the fresh
SET (Thurin et al., 2004). Observational 
studies have shown similar pregnancy and 
live birth rates after elective SET as after
DET, particularly in women under 35, with 
more than one good quality embryo, and 
when adding subsequent frozen-thawed 
cycles (Vilska et al., 1999, Lundin et al., 
2007, Veleva et al., 2009). 
In a study for selection of patients
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Figure 6. SET rates in fresh embryo transfers in 2000 and 2005. (The Swedish National 
Board of Health and Welfare, Nyboe Andersen et al., 2004 and 2009, Wright et al., 2003 
and 2008). 
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Table 3. Randomized SET-DET studies.  
 
 
SET DET
      
   Live Multiple Live Multiple 
 No. of Age birth birth birth birth 
 patients (years)  rate rate rate rate 
 
 
Gerris et al., 1999 53 <34 38.5ab 10.0a 74.1ab 30.0a
  
Martikainen et al., 144 21-40 29.7 4.2b 40.0 39.3b 
2001
 
Thurin et al., 2004 
Fresh+frozen SET 
versus fresh DET: 661 <36 38.8 0.8b 42.9 33.1b
Fresh SET versus 
fresh DET: 661 <36 27.6b 1.1b 42.9b 33.1b
 
Lukassen et al., 2005 107 <35 25.9c 0.0b 35.8 36.8b 
 
Van Montfoort et al.,  No age 
2006 308 limit 21.4ab 0.0ab 40.3ab 21.0ab 
 
Rates are in percentages.  
a (Multiple) ongoing pregnancy rate.   
bP<0.05.  
c The first SET of two in this study.
suitable for SET performed at our centre, it 
was shown that the woman’s age and the 
number of good quality embryos transferred 
were independent predictive factors for 
multiple births. The authors also developed
a prediction model for selecting patients for 
SET, based on age, cycle number and 
presence of tubal infertility (Strandell et al., 
2000). Another prediction model for 
selection of patients suitable for SET in mild
stimulation found the most important factors 
to be body mass index, the total 
gonadotropin dose needed, number of 
oocytes retrieved, and the availability of at
least one top-quality embryo (Verberg et al., 
2008b). An embryo scoring system for
prediction of implantation potential of day 2 
embryos was developed by another research 
group. The number of blastomeres,
mononuclearity in the blastomeres, and the 
blastomere size variation was found to be 
independent predictive factors for
implantation (Holte et al., 2007).
The delivery rate after transfer of a single 
blastocyst has been shown to be higher than 
after transfer of a single cleavage stage 
embryo, 32.0% versus 21.6% in an RCT 
including women of less than 36 years of 
age (Papanicolau et al., 2006). In an 
observational study, the delivery rate was 
36.7% for single blastocyst transfer and 
25.1% for single cleavage stage embryo
transfer (Guerif et al., 2009). However,
owing to smaller number of embryos 
available for freezing and lower survival 
rates after thawing in the blastocyst group, 
the cumulative delivery rates were similar in 
the two groups, 37.9% and 34.2%, 
respectively (Guerif et al., 2009).
The SET rate has also increased in
frozen-thawed cycles in Sweden, from 22%
in 2000 to 65% in 2004. Despite this, the 
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delivery rate per frozen-thawed embryo
transfer in total rose from 16% in 2000 to 
21% in 2004, and per frozen-thawed SET 
from 9% in 2000 to 17% in 2004 (The 
Swedish National Board of Health and 
Welfare).
In a systematic review of articles about 
economic considerations, DET was shown 
to be more expensive but also to result in 
significantly higher live birth rates than 
SET. SET was more cost-effective than
DET only when performed in good 
prognosis patients and when frozen-thawed 
cycles were included (Fiddelers et al., 
2007). In a study on cost-effectiveness
including the same randomized study 
population as in Paper IV, SET was found to 
be more cost-effective than DET when the 
number of deliveries with at least one live-
born child, incremental cost-effectiveness
ratio and maternal and paediatric
complications were taken into consideration
(Thurin-Kjellberg et al., 2006). 
Despite the availability of SET for more
than ten years, implementation has been
limited outside the Northern countries, the 
Netherlands and Belgium (Table 2, Nyboe
Andersen et al., 2009). The reason for this is 
mainly the lower success rates in SET as 
compared with DET. In the USA, IVF 
treatments are usually given at private 
clinics, which are highly competitive,
leading to stronger emphasis on high live 
birth rates in the USA than in the publically
funded clinics in Europe. An investigation 
among professionals in The Netherlands to 
determine why elective SET is not 
implemented more often showed that poor 
live birth rates in frozen-thawed cycles, not 
seeing twin pregnancies as a complication,
and lack of a SET protocol were the main
reasons, and that professionals with 
university hospital background were more
willing to perform elective SET than others
(Van Peperstraten et al., 2008). Attitudes
towards multiple birth and SET were 
recently investigated among Nordic IVF 
doctors. It was shown that almost all doctors 
thought that a singleton pregnancy was more
favourable than a twin pregnancy, and a
twin rate above 10% was acceptable for 5%
of Swedish doctors, 21% of Finnish doctors, 
and 35% of Danish and Norwegian doctors 
(Bergh et al., 2007). For women under 36, 
performing their first cycle and with two 
good quality embryos, almost all doctors 
would recommend SET, while for women
over 36 in a similar situation, only Swedish 
and Finnish doctors would recommend SET 
(Bergh et al., 2007). 
In a study where IVF patients were asked 
about reasons for choosing SET, it was 
shown that positive predictive factors were
if the patient had confidence in the 
possibility of a pregnancy with SET, was of 
a younger age and was undergoing her first 
treatment, while sense of time urgency was 
a negative predictive factor (De Lacey et al., 
2007). The doctor’s attitude toward SET 
was also an important predictive factor (De
Lacey et al., 2007). 
Patients dropping out of IVF 
treatment
In Sweden and some other countries, 
treatment programmes consisting of several 
IVF treatment cycles or up to one live birth 
are offered, fully subsidised, to infertile
couples. In countries without reimbursement
the patients are free to perform any number
of treatments but have to pay for them out of 
their own pockets. In spite of reimburse-
ment, a large number of patients drop out of 
treatment before having achieved a live birth 
or gone through the full treatment program.
The dropout rates reported in studies varies; 
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64% of the patients with no live birth after 
the first cycle in a British study (Sharma et 
al., 2002), 39.9% after the first cycle and 
62.2% after the fourth cycle in a German
study (Schroder et al., 2004) and 62.4% 
after three cycles in a Dutch study (Land et 
al., 1997). In countries with no 
reimbursement of IVF treatments, inability
to pay for further treatments is a common 
reason for discontinuing treatments
(Rajkhowa et al., 2006).
The most important reason for dropping 
out of treatment has been found in several 
studies to be psychological distress 
Rajkhowa et al., 2006, Verberg et al., 
2008a). “Active censoring”, i.e. discourag-
ing the patient from further treatment due to 
poor prognosis, is a reason for dropping out 
for some patients. Women who drop out of 
treatment in advance have been shown to 
have a poorer prognosis than those who 
continue (Land et al., 1997, Sharma et al., 
2002, Malizia et al., 2009). Other reasons 
for patient dropout are divorce, moving,
adoption or ethical objections to ICSI 
treatment after failed IVF (Verberg et al., 
2008a).
High dropout rates have a negative 
impact on the cumulative live birth rates. 
When calculating cumulative rates with life 
table analysis the reasons for dropping out 
are important, since if a large proportion of 
the dropouts are attributable to poor 
prognosis, this leads to overestimation of the 
live birth rates (Stolwijk et al., 1996). 
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Aims of the study 
General aims
The general aims of the study were to investigate cumulative live birth rates after IVF and 
factors affecting the live birth rates. 
Specific aims 
The specific aims of the study were to investigate: 
a. Cumulative live birth rates in a treatment programme consisting of three fresh IVF 
cycles and subsequent frozen-thawed cycles. 
b. The reasons why couples chose to discontinue the treatment programme in advance, 
before having achieved a live birth. 
c. Predictive factors for achieving a live birth in frozen-thawed SET.
d. Cumulative live birth rates after fresh SET and DET respectively, including 
subsequent frozen-thawed cycles. Follow up from a Scandinavian randomized
controlled trial (Thurin et al., 2004).
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Methodological considerations 
Settings and study designs 
All four studies were performed at the 
University of Gothenburg, Sweden with 
patients from the Centre for Reproductive 
Medicine, Sahlgrenska University Hospital. 
Paper IV was a multicentre study including
patients from eleven clinics in Sweden, 
Denmark and Norway, both public and 
private, and was based on an earlier trial 
from this unit (Thurin et al., 2004). The fact
that three IVF treatments are subsidised in
this region of Sweden, makes an appropriate 
setting for studies on cumulative live birth
rates (Paper I). The subsidy of IVF 
treatment is an important factor when 
studying reasons for dropping out of IVF 
treatment (Paper II), since financial 
constraints seldom is the main cause for that 
in countries with reimbursed IVF treatment.
SET cycles have constituted a large
Table 4. Study settings and patients 
 
Paper I Paper II Paper III Paper IV 
 
Setting            Sahlgrenska University Hospital  Scandinavian 
     multi-centre 
     
 
Study design Retrospective Prospective Retrospective Retrospective
 observational observational observational observational 
    
 
Study period 1996-1997 2003-2006 2000-2008 
 
 
No. of women 974  371 661 
 
No. of fresh and frozen-     
thawed cycles 1914  622 1261 
 
 
Age (years)¶ 32.5 (21-40) 32.2 (22-40) 30.9 (21-35) 
 
Infertility diagnoses, (%)* 
   -Male factor 33.5  46.4 51.9 
  -Tubal pathology 22.9  9.7 19.7 
  -Other female factors 13.6  21.8 18.2 
  -Multifactorial 10.7  - - 
  -Unexplained infertility 19.3  22.1 19.1 
¶Age at beginning of first treatment cycle.  
*Other female infertility factors include hormonal factors, endometriosis, and polycystic ovary syndrome. In 
Paper IV, some patients had several diagnoses.  
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proportion of the IVF treatments in Sweden 
since 2003,  leading to good prerequisites 
for performing SET studies (Papers III, IV). 
Papers I, III and IV were retrospective
observational studies. Cumulative live birth 
rates were calculated in both Papers I and
IV, but in Paper IV as opposed to Paper I, 
the patients were randomized to two groups, 
having undergone either SET or DET in a 
previous RCT. Paper II was a prospective 
observational study, since most of the data 
were not available but had to be collected 
through questionnaires.
Patients
Paper I: To assess the cumulative live
birth rates in paper I, around one thousand 
patients were considered a sufficiently large 
number. The collection of data took place 
during late 2000 and 2001. All consecutive 
patients who had begun their first IVF 
treatment cycle between January 1996 and 
December 1997 were included, a total of
974 patients. The relatively short inclusion 
time period of two years and the fact that all 
treatments were performed at the same 
clinic implied that there were no major
variations in the treatment methods. There 
were no major changes in methods or staff 
during that time period. Some other 
cumulative studies have included larger
number of patients, for example 6,164 
patients with treatments over six years 
(Malizia et al., 2009) and 2,130 patients 
with treatments over seven years (Schroder 
et al., 2004). Such long inclusion periods 
might be disadvantageous since the IVF 
technology and treatment results have 
developed and changed rapidly over time.
Paper II: Based on the same patient 
cohort as in Paper I and including the 450 
out of 974 patients who did not achieve a 
live birth.  The reasons were investigated as 
to why 288 out of the 450 patients who did 
not achieve a live birth discontinued their 
IVF treatment before having completed their
three subsidized IVF cycles. Inclusion of 
consecutive patients as used in Paper II was
also the inclusion method in other studies on 
reasons for dropping out (Rajkhowa et al., 
2006, Smeenk et al., 2004). The data were 
collected during 2002 and 2003. 
Paper III: The aim in paper III was to
study predictive factors for live birth in 
frozen-thawed SET cycles. The data were 
collected in 2007. All consecutive patients 
performing fresh IVF/ICSI cycles in 2003 
and 2004 with at least one additional frozen-
thawed SET were included. SET had, during 
this time period, become increasingly 
common in both fresh and frozen-thawed 
cycles. The choice to study only SET cycles 
was also due to the fact that it is more useful
to study embryonic variables in SET cycles 
since in case of a pregnancy it is clear which 
embryo implanted. A majority of previously 
published studies on predictive factors for 
live birth in frozen-thawed cycles have 
included cycles with two or more embryos
transferred (Salumets et al., 2006, Edgar et 
al., 2007). The inclusion time period was 
relatively short and the patients were all 
treated at one centre, which ensured similar
treatment methods. Both variables
associated with the fresh cycle, such as 
ovarian stimulation, number of egg retrieved 
and fertilization method, as well as variables 
associated with thawing, were included. Of 
the 922 women treated at our centre during 
2003 and 2004, 371 (40.2%) could be 
included in the study since their fresh cycles 
resulted in one or several frozen-thawed 
SETs. The 371 women performed 410 out of 
a total of 1,276 fresh cycles (32.1%) during 
that time period, resulting in 622 frozen- 
thawed SETs. The frozen-thawed SETs
28
 Figure 7. Flow chart of the women participating in Papers I and II.
 
Figure 8. Flow chart of the women participating in Paper III. 
974 patients 
started IVF treatment in 
1996-1997 
524 patients 
achieved a live birth after 
three available IVF cycles 
450 patients  
did not  
achieve a live birth 
162 patients  
completed  
three IVF cycles 
288 patients did not 
complete three IVF cycles  
Reason for dropping out  
found in medical records in 
77 patients 
Reason for dropping out  
investigated by 
questionnaires in 211 
patients 
922 women underwent 
1276 fresh cycles 
in 2003 and 2004 
 
708 women, with 880 
fresh cycles, had ?1 
embryo cryopreserved 
 
214 women, with 396 
fresh cycles, had no 
embryo cryopreserved 
371 women, with 410 
fresh cycles, underwent
622 frozen-thawed SET 
(study group) 
60 women had only 
DET in their frozen-
thawed cycles 
 
277 women had no 
frozen-thawed cycles 
 
153 women achieved a 
delivery in the fresh 
cycle 
 
124 women had other 
reasons (no thawing or 
no survival of embryos) 
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 661 were included in
the RCT 
 
 
 
 
 
 
330 were 
randomized to SET 
(1+[1] embryos) 
331 were 
randomized DET 
(2+0 embryos) 
 
 
 
 
 
 229 cryopreserved 1
to 15 embryos 
 
101 cryopreserved 
no embryos  
 
259 cryopreserved 1
to 15 embryos 
72 cryopreserved no
embryos 
 
 
 
 
 
 
70 destroyed all 
cryopreserved 
embryos 
 
90 destroyed all 
cryopreserved 
embryos 
 
 
 
 
 
 
 18 intended frozen-
thawed cycles but 
no embryos survived
17 intended frozen-
thawed cycles but 
no embryos survived
 
 
 
 
 
 
152 underwent  
1 to 4 frozen-thawed
cycles 
 
 
 
 
 
141 underwent  
1 to 4 frozen-thawed
cycles 
 
Figure 9. Flow chart of the women participating in Paper IV.  
were performed from March 2003 toOctober 
2006, and during that time 1,333/1,797 
(74%) of all frozen-thawed cycles were 
SETs.
Paper IV: A follow up of an RCT in 
which 661 women were randomized, as 
being below 36 years of age at the time of 
the transfer of the fresh embryo, undergoing 
their first or second IVF cycle, and with at 
least two embryos of good quality available 
for transfer or freezing. The recruitment
took place from May 2000 to October 2003 
at eleven clinics in Sweden, Norway and 
Denmark.  In the RCT, 330 were 
randomized to one fresh SET, and if this did 
not result in a live birth, one frozen-thawed 
SET was performed. Three hundred and 
thirty-one women were randomized to one
fresh DET. Demographics of the two groups 
did not differ in predicting variables. 
Surplus embryos of good quality (see 
definition below) were cryopreserved. After 
completion of the RCT, the patients could 
use their cryopreserved embryos in 
additional frozen-thawed cycles, in which 
one, two and sometimes three embryos were 
transferred according to the patient’s wish.
The results from the additional frozen-
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thawed cycles were added to the results
from the RCT, to investigate cumulative live
birth rates. 
The patients included in all four Papers 
were below 40 years of age when treatment
started. The reason for this is the 
reimbursement rules; when these studies 
took place, women had to be below 38 years 
of age when referred to be offered 
reimbursement IVF treatment at our clinic.
A non-negligible proportion of the IVF 
patients treated with IVF in society are,
however, older than our study population. In 
2005, 11.0% of all fresh embryo transfers 
were performed on IVF women over 40 
years in Sweden (The Swedish National 
Board of Health and Welfare).
.
Ethical considerations 
Paper I was a retrospective register
study, and with the legislation at that time
there was no need for ethics committee
approval. Papers II, III and IV were 
approved by the local ethics committee.
Sample size calculation 
In Papers I and II no power calculation
was performed since these were descriptive 
studies with no comparisons of interven-
tions or different groups of patients. In 
paper III a post-hoc power calculation was
performed, showing that with the number
of patients included in the study and with a 
live birth rate of 17% in the first cycle it 
was possible to identify a difference of at 
least 9% in live birth rate between the first
and second frozen-thawed SET from the 
same egg retrieval procedure (80% power, 
? = 0.05, two-tailed test). A power calcula-
tion was made in the original RCT of which 
Paper IV was a follow up, assuming that 
with a true live birth rate in the two groups 
of 0.30, the upper limit of the 95% CI of 
the observed difference in live birth rates 
between the groups would not exceed 0.10 
(Thurin et al., 2004, 80% power, ? = 0.05, 
two-tailed test).
IVF procedures 
Down-regulation of the gonadal axis was
performed using a GnRH agonist in a long 
protocol. Ovarian stimulation was 
performed using recombinant FSH or urine-
derived human menopausal gonadotropin. 
Stimulation was monitored by vaginal 
ultrasound and serum estradiol measure-
ments. Oocytes were retrieved 36-38 hours
after hCG injection using ultrasonographi-
cally guided puncture. Fertilization was 
achieved by standard IVF or by ICSI using 
standard protocols. Embryo transfer or
freezing of good quality embryos (GQEs, 
see below, terms and definitions) were 
performed on day two or three (in some
patients in Paper IV on day five). Luteal 
support was given with vaginal or 
intramuscular progesterone until the day of a 
negative pregnancy test or two weeks after a 
positive pregnancy test.
GQEs not used for fresh transfer were 
cryopreserved, using a propanediol-based 
slow freezing protocol. Usually embryos
were frozen and thawed one by one, 
particularly when the fresh transfer was a 
SET. After thawing, embryos were 
transferred on the same day. Usually only 
embryos with >50% survival of cells were
transferred. Embryo transfers were 
performed mostly in natural cycles that were
monitored by vaginal ultrasound and urinary 
LH, with the embryos being transferred on 
day three after the natural LH surge. For
anovulatory patients, hormone replacement
therapy with oral estrogen and vaginal 
progesterone was given, and if a pregnancy
ensued, the treatment continued until week 7.
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Data collection
In Papers I and III, data on patients and 
IVF treatments were collected from local 
IVF databases and medical records. After
coding, data were established in a research 
database. In Paper IV, data on the 
cryopreserved embryos and additional
frozen-thawed cycles were collected from 
all participating clinics. At some clinics a 
nurse, embryologist or the doctor responsi-
ble for the study filled out the data on a 
special data sheet and sent it to the study 
group, while we ourselves visited the other 
clinics to collect data.
Questionnaires
In Paper II all patients’ medical records
were primarily screened. In most cases it 
was not obvious why the patient discontin-
ued treatment in advance. To the 211 
patients whose reason for dropping out was 
not evident from their medical records, a 
questionnaire was sent out (Figure 10). If
there was no response, the questionnaires 
were sent to the patients a total of three 
times. The questionnaire was drawn up by 
our own research group, since there was no 
pre-existing validated questionnaire for this 
question.
Some other studies have also, in addition
to using their own questionnaires to get 
answers to the specific question of reason 
for dropping out, assessed the patients using 
standardized psychological questionnaires
such as State and Trait Anxiety Inventory, 
Becks Depression Inventory, Maudsley 
Marital Questionnaire, Hospital Anxiety and 
Depression scale (Smeenk et al., 2004, 
Verberg et al., 2008a). Questionnaires used 
in other studies on IVF patients’ 
psychological well-being and coping 
behaviour include the validated 
Psychological General Well-Being index
(Anderheim et al., 2005, Holter et al., 2006), 
Ways of Coping Questionnaire (Peterson et 
al., 2006), SF-36 (Thurin-Kjellberg et al., 
2006), Fertility Problem Inventory (Boivin
et al 2005, Peterson et al 2006), and Daily 
Record Keeping Chart (De Klerk et al., 
2008). The reason for not using any of these 
standardized psychological questionnaires in 
our study was that our aim was to 
investigate the reasons for dropping out and 
not primarily the patients’ psychological 
well-being.
The questionnaire used in Paper II was 
designed with tick-box alternatives (Figure 
10). The advantage of statements with tick-
box alternatives is that they are easily 
understood, quickly to complete, and 
measure general attitudes (Boynton, 2004a). 
Using pre-formulated tick-box alternatives 
is referred to as a closed-ended design, and 
makes it easy to produce data quickly, 
although it can give rise to frustration in the 
responders since their opportunity to express 
opinions and emotions is limited. For that 
reason, an open-ended design was also used. 
Free text boxes were inserted under each
category of reasons, and the patients were 
also given free text rows for expressing
general points of view and making
suggestions as to how to improve treatment.
The data analysis of the open-ended 
questions and free text alternatives is, 
however, somewhat more complicated as 
compared with the closed-ended questions 
(Boynton, 2004ab). In Paper II we chose to 
present the patients’ quotations after having 
divided them into different categories such 
as emotional and stressful reactions
attributable to the infertility situation,
organizational problems, the staff having a 
poor ability to handle patients in 
psychological distress, lack of autonomy 
during treatment and satisfaction with the
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Questionnaire to couples who discontinued IVF treatment
 
Our reason for discontinuing IVF treatment was (put an X in the relevant box.  
You may mark one or several boxes): 
 
Financial reasons 
 
? We were not offered more treatments by our county council 
??Private payment, could not afford more treatments 
??Other reason, specify  
 
Medical reasons 
 
??Our IVF doctor discouraged us from further treatment owing to a poor  
 prognosis 
??Other medical reasons, such as severe illness 
??The treatment was too physically demanding 
??The treatment was too psychologically demanding 
??Other reason, specify 
 
Social reasons 
 
??Separation and relationship problems 
??Moved from the region 
??Other reason, specify 
 
View of the treatment 
 
??Good 
??Less than good 
??Poor 
 
What can we do to improve the treatment? 
---------------------------------------------------------------------------------------- 
 
---------------------------------------------------------------------------------------- 
 
Other opinions? 
 
---------------------------------------------------------------------------------------- 
 
---------------------------------------------------------------------------------------- 
 
 
Name Personal identity number 
 
------------------------------------------- ------------------------------------------- 
 
 
 
SAHLGRENSKA UNIVERSITY HOSPITAL
Figure 10. Questionnaire in Paper II.
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care. The free-text comments also
contributed in some cases to the decision as
to which reason for dropping out was most
important, since some patients had ticked 
several boxes and only one main reason per 
patient was registered. One common reason 
for low response rates is that the responder 
cannot follow or understand the 
questionnaire, so the questions should 
generally be short and to the point, twelve 
words or less (Boynton, 2004a), with which 
the questionnaire in Paper II is well in 
accord. The questionnaires were only sent 
out in Swedish language, since we assumed
that patients with poor understanding of 
Swedish could get help with reading it from
relatives or friends. This could be a possible 
weakness in our methodology. A 
considerable proportion of the patients today 
do not have Swedish mother tongue, and 
many need a professional interpreter at 
appointments. The woman’s name in each 
couple was written on the envelope, but the 
questionnaire itself was addressed to the
couple. The fact that only the woman’s
name was written on the envelope may have 
been perceived as an exclusion of the man in 
the couple, and could be another weakness. 
The couples were allowed to tick several 
boxes in the questionnaire, giving more than 
one reason for discontinuing treatment.
However, when we summarized the results
only one reason per couple was registered. 
In the cases where more than one reason 
was given, the absolute reasons such as
having moved from the area, not being 
offered more treatments from the county 
council, discouragement from further 
treatment by the doctor, or divorce, were 
chosen over more relative reasons such as 
psychological or physical strain. In unclear 
cases the members of the research group
reached a common decision. A better design 
of the questionnaire would have been to 
explicitly ask for the main reason, and invite 
the couples to make further comments on 
other contributing reasons. 
Terms and definitions
Poor prognosis: In Papers I and II, the
medical records of patients who dropped out 
of treatment were screened. The couples 
were interpreted as having discontinued 
treatment because of a poor prognosis if it 
was found that they had very poor embryo
quality, poor ovarian response on stimula-
tion or recurrent pregnancy loss.
“Troublesome treatment”: In Paper I,
patients were labelled as having discontin-
ued treatment because of “troublesome
treatment” if there were comments in the 
medical records concerning exceptional 
psychological or physical strain or if the 
couple had explicitly informed their doctor 
they wanted to quit treatment because it was
too troublesome.
Started and completed cycles: In Paper I,
the live birth and pregnancy rates were 
reported per started and per completed 
cycle. Started cycle describes all cycles 
where ovarian stimulation was initiated with
gonadotropins, and completed cycles 
describes all cycles that reached embryo
transfer. Live births achieved in subsequent 
frozen-thawed cycles were included in the
fresh cycle from which the cryopreserved
embryos had originated. Most other studies 
on cumulative live birth rates have reported 
outcome only per started cycle (Alsalili et 
al., 1995, Engmann et al., 1999, Witsenburg
et al., 2005, Malizia et al., 2009). The 
previous report on cumulative live birth 
rates from our centre, however, also 
presented results both per started and per 
completed cycle (Bergh et al., 1995). The 
reason for presenting rates per completed 
34
cycle, and including results from frozen-
thawed cycles in each fresh cycle, was that 
that was in accord with our reimbursement
system.
GQE: In Papers III and IV, GQEs were 
defined as being of grade I or II, having 4-6 
cells on day two or 6-10 cells on day three, 
with less than 20% fragmentation and no 
multinucleation.  In Paper III embryo grade 
was one of the variables analyzed: Grade I 
embryos were GQEs with no fragmentation 
and even-sized cells, Grade II embryos were 
all other GQEs. 
Statistics
For descriptive data, sum, percentage, 
mean, median, standard deviation (SD) and 
range were used. Comparisons of categori-
cal variables between groups were done 
using Fisher’s exact test and the Chi-square 
test. For continuous variables, Student’s t-
test was used for parametric data and Mann-
Whitney U-test for non-parametric data. A 
p-value of less than 0.05 was considered 
significant and 95% confidence intervals 
(CI) were used. All significance tests were
two-sided. The statistical analyses were 
done in collaboration with professional 
statisticians, and SPSS (version 13.0 and 
16.0) and SAS (version 8.2) were used as 
statistical computer software. 
Analyzed variables
Paper I: Cumulative pregnancy and 
cumulative live birth rates after three
completed and started IVF cycles,
respectively. Pregnancy and live birth rates 
per started and per completed cycle. The 
variables were analyzed both in the total 
patient group and according to the woman’s
age and the couple’s reason for infertility. 
Paper III: Univariate analyses of preg-
nancy and live birth were performed for:
woman’s age, tubal factor, fertilization
method, number of fresh and cryopreserva-
tion cycles in patient's history, number of 
failed fresh and failed cryopreservation 
cycles in patient's history, total and failed
number of cryopreservation cycles from the
same fresh cycle, pregnancy or live birth in 
the fresh cycle, pregnancy or live birth in 
any previous cryopreservation cycle from 
the same fresh cycle, surgically retrieved
sperm, blastomere survival rate, number of 
cells in the thawed embryo, embryo quality 
grade, number of embryos needed to be 
thawed in order to obtain one embryo
transfer, hormone stimulated cryopreserva-
tion cycle, number of oocytes aspirated in 
the fresh cycle, number of GQEs in the fresh 
cycle, FSH/hMG-dose per aspirated oocyte. 
Variables associated to pregnancy or live 
birth with p<0.10 were included in the 
multivariate analysis.
Paper IV: The SET and DET groups
were analyzed according to the intention-to-
treat principle. Cumulative live birth rates 
and multiple birth rates were analyzed as 
main variables. Mean number of live births, 
mean number of live-born children, mean
number of additional cryopreserved
embryos, mean number of additional frozen-
thawed cycles, number of embryos transfer-
red per additional frozen-thawed cycle,
mean number of pregnancies, mean number
of miscarriages, intrauterine foetal death 
rates, ectopic pregnancy rates, mean
gestational age and preterm birth rates were 
analyzed as secondary outcomes.
Life table analysis
When calculating cumulative success
rates, life table analysis is the most frequent-
ly used statistical method (Stolwijk et al., 
2000, Engmann et al., 1999, Malizia et al., 
2009). The life table analysis, also called the 
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Kaplan-Meier survival curve, is otherwise 
typically used in clinical studies to estimate
the probability of survival during a given 
length of time, for example after cancer 
treatment. The total length of time is divided
into many smaller intervals, for example
days or weeks. The probability of one-year 
survival can be expressed as a multiplication
of the probability of surviving each week, 
each week having a different p-value, since 
it is on the condition that the object survived
the previous weeks:
p1 x p2 x p3 x …. p52 = ptotal
In cumulative IVF studies, the time unit is 
translated to treatment cycles, and the 
probability of achieving a live birth after a 
certain number of treatment cycles is
assessed. The model used in Paper I is 
called the Kaplan-Meier product-limit
estimate, where the cumulative probability
of achieving a live birth after x number of 
cycles, in which px is the probability of
achieving live birth in cycle x, is: 
[1 - (1 - p1)(1 - p2)…(1 - px)] x 100% 
Patients who discontinued the treatment
programme, despite not having achieved a 
live birth, are referred to in the life table 
analysis as censored, and are given the same
probability of the endpoint, in this case 
pregnancy or live birth, as those who 
continued. This is generally believed to 
cause an overestimation of the cumulative
live birth rates, since the patients who 
discontinued the treatment program include 
women who were actively discouraged from
further treatment owing to a poor prognosis. 
Some studies have shown that women who 
discontinue treatment have a poorer 
prognosis as a group than those who 
continue (Sharma et al., 2002, Malizia et al., 
2009). Other studies, however, found no 
prognostic differences between women who 
dropped out of treatment and those who 
continued (Roest et al., 1998, De Vries et 
al., 1999).
To solve the problem of suspected
overestimation, a modified life table 
analysis was introduced in 1996 yielding 
three estimates: one “pessimistic” where the
dropout group was given no chance of 
pregnancy (observed, real rates); one 
“optimistic” where the dropouts were given 
the same chance of live birth as those who 
continued treatment (standard life table 
analysis); and one “realistic” where women
who discontinued treatment because of a 
medical condition were given no chance of 
live birth while the others were given the 
same chance as those who continued
(Stolwijk et al., 1996). The realistic estimate
is believed to be the most accurate (Stolwijk
et al., 1996). In recent cumulative studies, 
the authors have chosen to present only the 
pessimistic and the optimistic estimates
(Schroder et al., 2004, Malizia et al., 2009). 
One reason for this could be that the realistic 
estimate requires extra effort, since the 
reasons for dropping out have to be 
established. In Paper I, we used life table 
analysis with these three different ways of 
handling dropouts producing one 
“pessimistic”, one “realistic”, and one 
“optimistic” estimate.
Log-rank test 
The most frequently used method for 
comparing survival curves of independent 
groups is the log-rank test, which tests the 
null hypothesis that the groups are samples
from the same population. In paper I, the 
log-rank test was used to test differences 
between the age groups and infertility 
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 Table 5. Statistical methods used in Paper I-IV. 
 
 
Paper I Paper II Paper III Paper IV
 
 
Significance 0.05, two-sided tests 
level  
      
 
Descriptive  Mean, SD, range Sum, percent Mean, SD, Median, Mean, SD, range 
statistics   range  
 
Analytical  Fisher’s exact test  Fisher’s exact test  Fisher’s exact test  Fisher’s exact test 
statistics Chi-square test Student’s t-test Mann-Whitney U- Chi-square test
 Life table analysis  test Mann-Whitney U- 
 Log rank test  Univariate analysis test 
   Multiple regression 
   analysis 
 
 
 
 
diagnosis groups. 
Multiple regression analysis
In Paper III we used multiple regression
to analyze how the different maternal and
embryonic variables influenced live birth 
rate and pregnancy rate. Multiple regression
is used to investigate the way one dependent
variable is influenced by several other 
variables, referred to as independent 
variables. Multiple linear regression is the
method used when the dependent variable is 
continuous, while if the dependent variable 
is categorical, the method is referred to as 
multiple logistic regression, or just logistic 
regression. One pitfall with multiple
regression analysis is if too many variables 
are used on too small a sample, because this
may lead to an overestimation of each 
variable’s importance. There is a general 
recommendation not to look at more than 
n/10 variables, where n is the sample size. In 
Paper III we investigated 24 variables in 371 
patients, which was correct according to the 
recommendation above. However, the large 
number of variables studied in Paper III 
increased the risk of random findings. The 
analysis in Paper III was initiated with a
univariate analysis, investigating the 
correlation between each independent
variable and the dependent variable. All 
independent variables that correlated with 
the dependent variable with a p-value of less 
than 0.10 were then included in the multiple 
regression analysis. 
To estimate the predictive value of the 
regression model, the c-value (which is the 
same as area under curve) of the prediction 
model in Paper III was calculated, and was 
found to be 0.60 (1.0=very good, 0.5=poor). 
The relatively low c-value means that the
predictive capacity for the end point (live 
birth or pregnancy), of the variables that 
were found to be significant in the multiple 
regression analysis, was not very high. 
In Paper III, the generalized estimation
equation (GEE) method was used to adjust 
for the dependence within each woman,
since more than one cryopreservation cycle 
per woman was included. The GEE method
is an extension of the generalized linear 
model, developed to better suit the analysis
of longitudinal or clustered data and to 
avoid random findings when unknown 
correlations are present (Ghisletta et al., 
2004).
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Results and comments 
PAPER I: Cumulative live birth rates
after three IVF/ICSI cycles 
All cycles performed by the patients
during the study time period are presented in 
Table 6. To complete three IVF cycles, the 
patients in the study underwent up to six 
started cycles, since in some cases several 
cycles were cancelled before embryo
transfer. In spite of the fact that no more
than three completed cycles were offered,
sixteen patients in the study population 
underwent four completed cycles. The 
reasons for this were, in some cases, 
repeated extra-uterine pregnancies or 
spontaneous miscarriages. The fourth 
completed cycles in the sixteen cases were 
not included in the analyses. All results
presented below are based strictly on the 
patients’ first three completed cycles and 
their corresponding started cycles. 
The 974 women started 1,985 IVF cycles 
 
 
 
Table 6. Cumulative live birth rates per started and completed cycle. The extra cycles are 
in parenthesis and are not included in the cumulative analyses. 
 
 
 Cycle Fresh Frozen- Live Cumulative live birth rate, % (95% CI)____
 no. cycles thawed births* Pessimistic Realistic Optimistic 
   cycles  estimate estimate estimate 
 
 
Started 1 974 203 296 30.4 30.4 30.4 
cycles    (30.4%) (27.5-33.3) (27.5-33-3) (27.5-33.4) 
 
 2 588 96 140 44.8 46.7 47.0 
     (23.8%) (41.6-47.9) (43.5-50.0) (43.7-50.2) 
 
 3 314 23 60 50.9 56.3 57.1 
    (19.1%) (47.8-54.1) (52.9-59.8) (53.6-60.6) 
 
 4 103 5 29 54.7 65.2 69.2 
    (28.2%) (51.5-57.9) (61.2-69.2) (64.7-73.7) 
 
 (5) (19) (1) (2) - - - 
    (10.5%) 
 
 (6) (3) (-) (1) - - - 
    (33.3%) 
 
 
Completed 1 944 175 331 35.1 35.1 35.1 
cycles    (35.1%) (32.0-38.1) (32.0-38.1) (32.0-38.1) 
 
 2 491 73 135 49.4 52.1 52.9 
    (27.5%) (46.2-52.6) (48.8-55.5) (49.5-56.3) 
 
 3 217 12 58 55.5 63.1 65.5 
    (26.7%) (52.4-58.7) (59.6-66.7) (61.8-69.2) 
 
 (4) (16) (2) (4) - - - 
    (25.0%) 
 
*Live birth rates per fresh cycle, births from frozen-thawed cycles included. 
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of which 1,652 cycles from 944 patients 
achieved fresh embryo transfer (“completed
cycles”). In 28 cycles all embryos were 
cryopreserved owing to impending ovarian 
hyperstimulation syndrome (OHSS) and 
used later in frozen-thawed embryo
transfers, these were also counted as 
completed cycles. 
A total of 260 frozen-thawed embryo 
transfers were performed with embryos
originating from the fresh cycles. The live
births from the frozen-thawed cycles were 
included into the results of the started/
completed cycle from which the embryos
originated. The majority of fresh and frozen-
thawed embryo transfers were with two
embryos. Standard IVF was used as the 
fertilization technique in the first IVF cycle
in 47%, ICSI in 51%, and both techniques 
were used in 2% (split cycles). 
The 1,912 fresh and frozen-thawed 
embryo transfers resulted in 524 live births. 
One singleton was stillborn, and in four twin 
pregnancies one twin was stillborn. There 
were a total of 678 pregnancies of which 
142 miscarried spontaneously, two were 
legally aborted owing to foetal polycystic
kidney disease and trisomy 3, and nine were 
extrauterine pregnancies. The twin birth rate
was 23% of all live births, no multiple birth 
of higher order occurred. 
Cumulative live birth rates 
The cumulative live birth rate for all 
patients after three completed cycles was
63.1% in the “realistic” estimate. The 
“pessimistic” outcome was 55.5% and the 
“optimistic” outcome was 65.5% (Figure 
11). The corresponding rates per three and 
four started cycles can be seen in Table 6.
The live birth rate per completed cycle was
35.1% in cycle 1, 27.5% in cycle 2, and 
26.7% in cycle 3 (p=0.004 cycle 1 versus 
cycle 2, p=0.02 cycle 1 versus cycle 3). The 
260 frozen-thawed cycles resulted in 52 live 
births, representing 10% of all live births in 
the study. The live birth rate per frozen-
thawed embryo transfer was thus 20.0%. In 
2001, when the last data was collected, 72 
patients still had embryos cryopreserved 
from the fresh study cycle. A follow up in 
2009 showed that no more live births from 
frozen-thawed cycles had been achieved.
Six of the patients had undergone additional
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Figure 11. Cumulative live birth rates after three completed IVF cycles.
40
frozen-thawed cycles, of which one resulted 
in a pregnancy that miscarried before week 
6. The other patients had had their 
cryopreserved embryos destroyed. 
Thirty-seven of the patients dropped out 
of the treatment owing to a spontaneous 
pregnancy. These live births were not 
included into the original analyses, but if 
they had been, the cumulative “pessimistic”
live birth rate after three completed cycles
would have been 59.4% (561/944). 
Seven of the patients included in the 
study were treated with artificial insemin-
ation (artificial insemination husband, AIH) 
which, in these cycles, had been transformed
to IVF due to a high number of follicles. In 
retrospect, these patients should not have 
been included in the study. The seven 
patients did not achieve any live births in 
their IVF cycles. When followed up in 2009, 
two of them had achieved live births in later
AIH cycles, not included in our analyses.  If 
these seven AIH patients were excluded and 
the thirty-seven spontaneous pregnancies
were included, the cumulative “pessimistic”
live birth rate after three completed cycles
would have been 59.9% (561/937). 
Age, infertility diagnoses and cumulative 
live birth rates 
The patients were divided into three age
groups depending on the age of the woman
when the treatment was initiated. The 
cumulative live birth rates after three
completed cycles are illustrated in Figure 
12, and were higher in the two younger age 
groups as compared with the relatively older 
age group (p=0.018 for 20-29 years versus 
35-40 years, p=0.0021 for 30-34 years 
versus 35-40 years). Women under 30 
delivered twins significantly more often 
than did women over 30, reflecting higher 
implantation rates (twin rate 34%, 19% and 
18% respectively; p=0.0008 and 0.0025). 
The cumulative live birth rates were also
compared for different infertility diagnosis 
subgroups (Figure 13). The differences were 
not statistically significant.
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Figure 12. Cumulative live birth rates after three completed IVF cycles for different age 
groups, “realistic” estimate. 
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Figure 13. Cumulative live birth rates after three completed IVF cycles according to 
infertility diagnosis, “realistic” estimate. (In the original publication, the curve was based 
on started cycles, why it looks slightly different). 
Patients who discontinued treatment
Of the 450 patients who did not achieve a 
live birth, 290 (see below why this number
differs along the text) left the treatment
programme before having completed three 
cycles. Thirty patients did not undergo any 
embryo transfer, 121/613 (19.7%) dropped 
out after one completed cycle, and 139/356 
(39.0%) after two completed cycles. The 
medical records of these 290 patients were 
searched to determine their reasons for
dropping out. Poor prognosis was the reason 
for 50 patients. In the “realistic estimate”,
these 50 patients with a poor prognosis were 
given no chance of a live birth, whereas the 
other dropouts were given the same chance 
of a live birth as those who completed their
cycles.
(%
)
Unexplained infertility (69.5%)
Other female factors (63.2%)
Male factor (63.7%)
Multifactorial infertility (61.1%)
Tubal pathology (58.6%)
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PAPER II: Why do couples discontinue 
IVF treatment? A cohort study. 
The reasons as to why a large proportion 
of the couples in Paper I discontinued their 
treatment was investigated in this study. Of 
the 290 patients reported as having 
discontinued treatment in Paper I, one 
completed three cycles with no live birth
after Paper I was published, and another was 
an AIH patient, and therefore they were no
longer considered dropouts. Thus, 288 of the
450 patients who did not achieve a live birth 
(64%) discontinued before completing three 
IVF cycles. The medical records of the 288 
couples were scrutinized. The reason for 
discontinuation was obvious in 77 cases. A
questionnaire was sent out to the remaining
211 couples. Of the 211 couples who 
received the questionnaire, 162 (77%) 
responded, of which one had sent back the 
questionnaire blank, without having 
answered the questions. No statistically
significant differences were found between
responders and non-responders concerning 
age of the women and or reason for 
infertility. The questionnaires showed that 
46 of the couples were only offered two 
cycles by their county council.  Thereby, of 
the 288 couples who did not complete three 
IVF cycles, 242 discontinued for reasons 
unrelated to the reimbursement system. In 
192 (79%) of the 242 cases, the reasons for
not undergoing more treatments could be 
identified either from medical records
(n=77) or questionnaires (n=115). 
Reasons for discontinuing IVF treatment 
The main reason for discontinuation was 
the psychological stress in 26%, poor
prognosis in 25%, spontaneous pregnancy in 
19%, physical factors in 6%, serious disease 
in 2%, and other reasons such as having 
adopted or moved in 7% (Figure 15). 
Psychological stress was caused by, for 
example, several previous failed treatments
for infertility, late miscarriage, legal 
abortion owing to foetal chromosomal
288 discontinued before 
completing three IVF cycles 
 
77: drop-out reason  
found in medical records 
 
211 patients were sent 
questionnaires 
  
 
 
162 patients answered the 
questionnaire 
 
49 patients did not answer 
the questionnaire 
 
 
 
 
 46 were offered only two 
cycles  
 
115 reported other reasons 
for dropping out  
 
 
 
 
One questionnaire was 
returned empty 
Figure 14. Flow chart over the participants and distribution of questionnaires in Paper II. 
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Figure 15. Reasons for discontinuing IVF treatment. 
abnormalities, seeing different doctors at 
each appointment, and feeling pressure to 
succeed with the treatment. Physical factors
included, for example, severe gynaecologi-
cal or abdominal infection, ovarian hyper-
stimulation syndrome, and pain from 
injections. The number of patients having 
discontinued treatment due to a poor 
prognosis was assessed to be 50 after the 
scrutiny of the medical records in Paper I, 
but changed to 48 after having investigated 
it also by questionnaires in Paper II. 
Free text comments and rating of the 
care
One hundred forty-three couples shared 
one or more free text comments. The 
comments were divided into five major
categories, as presented in Table 7. 
Comments concerning lack of autonomy
were the most frequent ones. The patients 
reported experiencing stressful “assembly-
line” treatment, and a need for more inform-
ation about alternatives to the treatment such 
as adoption, and about the treatment itself. 
The next most frequent comments
concerned experiencing not being listened 
to, and not being met with empathy, i.e. 
shortcomings in the psychological aspects of 
the care. Several of the patients reported that
they felt a need for psychological counsel-
ling. Another frequent remark was that the 
clinic had organizational problems, and that 
the patients wished to have more continuity 
in terms of the number of different 
caregivers they had to meet. On the other 
hand, a substantial number of patients 
reported positive experiences and a feeling
of being well taken care of. It should be 
born in mind that these comments derive 
from a negatively selected group, who did 
not achieve a live birth and who dropped out 
of treatment, and do not represent the 
average IVF patients. In the questionnaire 
the patients were invited to grade the care at 
the centre as “good”, “less good” or “poor”.
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Table 7. Free text comments from 143 patients on the care at the IVF clinic.  
 
Type of comment Example n*
Emotional and stressful reaction “We needed to talk to a psychologist” 22 
due to the infertility situation  
 “Couldn’t cope with more treatment” 3 
 
Organizational problems “Poor organization at the clinic” 23 
“Insufficient care of the man” 5
  
 “Never the same people from appointment  
 to appointment”  9 
 
Poor ability to handle patients  “The doctors and nurses didn’t listen to me”  18 
in psychological distress  
 “I wasn’t met with empathy”  21
“The doctors/nurses didn’t treat me nicely” 4 
 
Lack of autonomy during “Stressful, assembly-line treatment” 29 
treatment  
 “Needed more information concerning the 
 treatment and alternatives” 31 
 
Good care “Great commitment and professionalism  
despite high stress level, very well cared for”  23
* Some patients made more than one comment. 
Of the 152 patients who graded the care, 
100 (66%) depicted it as “good”, 35 (23%) 
as “less good” and 17 (11%) as “poor”. The 
ratings between those who discontinued of 
their own volition and those who were 
forced to discontinue since they were 
offered only two reimbursed cycles by their 
county council did not differ significantly.
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PAPER III: Predictive factors for live 
birth in frozen-thawed SET 
In this study, predictive factors for live 
birth in frozen-thawed SET were analysed in 
371 patients with fresh cycles during 2003-
2004 resulting in at least one frozen-thawed 
SET. The patients underwent 622 frozen-
thawed SETs during 2003-2006, resulting in 
97 live births (16%). One twin and 96 
singleton live births occurred. The 
pregnancy rate was 22%. The corresponding 
live birth and pregnancy rates for 
cryopreservation DET were 19% and 28%. 
Univariate analyses 
In the univariate analysis female age, IVF as
fertilization method, and blastomere
survival rate differed significantly between 
patients with and without a live birth (Table
8). For pregnancy, blastomere survival rate 
and the number of embryos thawed to obtain 
this transfer were significantly correlated.
All variables with a p-value of less than 0.10 
in the univariate analysis were included in 
the multivariate analysis.
Multivariate analysis 
The factors that were found to correlate 
independently to pregnancy and live birth 
are shown in Table 9. In the multivariate
analysis on predictors of live birth IVF as 
fertilization method, blastomere survival 
rate and number of fresh cycles in the 
patient’s history were found to be 
independent predictors. When the endpoint
was pregnancy, blastomere survival rate, 
number of fresh cycles in the patient’s
history and number of embryos thawed to 
obtain this ET were found to be independent 
predictors. That blastomere survival rate,
conventional IVF as fertilization method as 
compared with ICSI were positive
predictors, and the number of embryos
thawed to obtain one transfer was a negative
predictor, was not surprising since it is in 
accord with findings in other studies or can 
be explained by existing theories (see 
Discussion). It was an unexpected finding 
that the number of fresh cycles in the 
patient’s history was an independent 
predictor of live birth, but it might be 
explained by the fact that both previous
successful and failed cycles were included 
in the variable. When analysing the number
of failed fresh cycles in the patient’s history 
separately, this variable was not shown to 
affect the live birth rate. This can be seen as 
encouraging for couples who have 
undergone several previous failed fresh 
cycles. However, the mean number of 
previous fresh cycles in the patients’ history 
in this study was low, 1.3 and 1.2 in the 
groups with a live birth and with no live 
birth, respectively. In the group with a live 
birth in the frozen-thawed cycle, 16.5% had 
a live birth after the fresh cycle, as
compared with 12.2% in the group with no 
live birth after the fresh cycle, the difference
not being significant. It was somewhat
surprising that the woman’s age was not 
shown to be an independent predictor in the 
present study. Age is a well known predictor 
of live birth in IVF. The reason for this may
be the homogeneity in age in our study 
population.
Success rates according to cycle number
with eggs from the same egg retrieval 
The success rates in the first, second and 
third or more frozen-thawed cycles, when 
all earlier frozen-thawed cycles from the 
same egg retrieval had failed, were 
compared (Figure 16). There was no 
statistical difference in pregnancy or live 
birth rate irrespectively whether the patients
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Table 8. Univariate analysis of maternal and embryological factors investigated for 
influence on pregnancy and live birth rates.   
 
 
 Preg- No P Live No live P
nancy pregnancy (preg- birth birth (live
(n=138) (n=484) nancy) (n=97) (n=525) birth)
 
 
Age 32.7 (3.4) 32.1 (3.7) 0.060 32.9 (3.3) 32.1 (3.7) 0.039 
 
Tubal factor, n (%) 14 (10.1) 56 (11.6) 0.651 8 (8.2) 62 (11.8) 0.294 
 
Fertilization method, standard       
IVF, n %) 79 (57.2) 245 (50.6) 0.175 60 (61.9) 264 (50.3) 0.039  
 
Number of fresh cycles in       
patient’s history 1.3 (0.7) 1.2 (0.7) 0.061 1.3 (0.7) 1.2 (0.7) 0.070 
 
Number of cryo-cycles in  
patient’s history 1.8 (1.1) 1.8 (1.0) 0.663 1.7 (1.1) 1.8 (1.0) 0.403 
 
Number of cryo-cycles from       
the same fresh cycle 1.6 (0.9) 1.5 (0.8) 0.828 1.5 (0.8) 1.6 (0.8) 0.532 
 
Number of failed fresh cycles  
in the patient’s history 1.1 (0.7) 1.0 (0.8) 0.160 1.1 (0.7) 1.0 (0.8) 0.409 
 
Number of failed cryo-cycles       
in the patient’s history 0.8 (1.1) 0.7 (1.0) 0.556 0.7 (1.1) 0.8 (1.0) 0.473 
 
Number of failed cryo-cycles  
from the same fresh cycle 0.5 (0.8) 0.5 (0.8) 0.743 0.5 (0.8) 0.5 (0.8) 0.620 
 
Pregnancy in the fresh cycle,  
n (%) 37 (26.8) 114 (23.6) 0.455 26 (26.8) 125 (23.8) 0.535 
 
Pregnancy in previous cryo-cycle 
from the same fresh cycle, n (%) 12 (8.7) 27 (5.6) 0.165 6 (6.2) 33 (6.3) 0.938 
 
Either of the two previous  
variables, n (%) 44 (31.9) 137 (28.3) 0.444 30 (30.9) 151 (28.8) 0.682 
 
Live birth in the fresh cycle, n (%) 19 (13.8) 61 (12.6) 0.728 16 (16.5) 64 (12.2) 0.257 
 
Live birth in previous cryo-cycle 
from the same fresh cycle, n (%) 4 (2.9) 16 (3.3) 0.761 2 (2.1) 18 (3.4) 0.376 
 
Either of the two previous  
variables, n (%) 23 (16.7) 77 (15.9) 0.865 18 (18.6) 82 (15.6) 0.484 
 
Surgically retrieved sperm, n (%) 10 (7.2) 29 (6.0) 0.579 4 (4.1) 35 (6.7) 0.333 
 
Blastomere survival rate, in  95.4 91.3 0.002 95.5 91.6 0.008 
percent (10.3) (14.7)  (10.2)  (14.5)  
 
No of cells in the thawed embryo 4.0 (0.6) 3.9 (0.8) 0.462 4.0 (0.6) 3.9 (0.8) 0.358 
 
Embryo grade 1.8 (0.4) 1.7 (0.4) 0.423 1.7 (0.4) 1.8 (0.4) 0.861  
 
Number of embryos thawed to       
obtain this transfer 1.4 (0.7) 1.6 (0.9) 0.015 1.4 (0.7) 1.6 (0.9) 0.130 
 
Stimulated cryo-cycle, n (%) 28 (20.3) 107 (22.1) 0.642 16 (16.5) 119 (22.7) 0.184 
 
Number of oocytes aspirated in  
the fresh cycle 15.0 (6.7) 15.8 (7.1) 0.228 15.1 (7.0) 15.7 (7.1) 0.436 
 
Number of GQEs in the fresh  
cycle 6.3 (3.6) 6.2 (3.3) 0.611 6.5 (3.7) 6.1 (3.3) 0.223 
 
FSH/HMG dose per aspirated 182.8 184.0 0.889 185.4 183.4 0.938 
oocyte, in the fresh cycle (160.5) (215.0)  (173.4) (209.4)  
       
Numbers are expressed as mean (SD) unless otherwise indicated. 
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Table 9. Multivariate analysis of maternal and embryological factors investigated for 
independent relation to pregnancy and live birth. 
 
 
Pregnancy Live birth
 ____________________________________________________ ___________________________________________________  
 
 OR 95% CI P OR 95% CI P
 
 
Blastomere survival rate 1.025 1.008-1.042 0.003 1.026 1.007-1.045 0.007 
 
Number of fresh cycles  
in the patient’s history 1.312 1.014-1.670 0.039 1.372 1.031-1.826 0.030 
 
Fertilization method,  
standard IVF - - - 1.607 1.022-2.526 0.040 
 
Number of embryos  
thawed to obtain this  
transfer  0.772 0.602-0.990 0.042 - - - 
 
OR=odds ratio. CI=confidence interval. 
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Figure 16. Live birth rate and pregnancy rate, calculated by cycle number of frozen-
thawed SET, derived from the same oocyte retrieval, when all previous frozen-thawed 
SET from the same cohort of eggs had failed. The differences were not significant.  
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had undergone one, two or three or more
failed cryopreservation cycles from the 
same egg retrieval. However, the number of 
women performing a third or more frozen-
thawed cycle from the same egg retrieval 
when the previous ones had failed was 
limited (n=66), giving a low power to detect 
a difference in live birth rates between 
cycles. The fact that the number of thawed 
embryos required to perform one transfer 
was a significant negative predictor of 
pregnancy in the multivariate analysis may,
however, indicate that if there is a poor 
embryo quality in some of the eggs from a 
particular cohort, the chances of a live birth 
might be decreased when using other eggs 
from that cohort. This theory is called 
“cohort homogeneity” (see Discussion). 
49
PAPER IV: Cumulative Live-Birth
Rates after Single-Embryo versus 
Double-Embryo Transfer 
In this follow up study, all subsequent 
frozen-thawed cycles with embryos
originating from the fresh cycles in the RCT 
by Thurin et al. were traced, generating 
cumulative data. A major strength of the 
study was that no patients were lost to 
follow up and all embryos were accounted 
for. Of the 661 patients included in the RCT, 
141 patients in the SET randomization
group and 152 patients in the DET 
randomization group underwent additional
frozen-thawed cycles. Table 10 shows the 
characteristics of the frozen-thawed cycles.
A surprisingly large group of the patients 
did not use their cryopreserved embryos; 
30.6% in the SET group and 34.7% in the 
DET group had all their embryos destroyed 
(Figure 9 in Methodological considerations). 
Of these 31.4 % in the SET group and 
33.3% in the DET group had not achieved a 
live birth in the RCT. Of the patients who 
did not achieve a live birth either in the
original RCT or in the addition frozen-
thawed cycles, 17.8% in the SET group and 
22.2% in the DET group had at least one 
cryopreserved embryo destroyed. The 
patients’ reasons for not using their 
cryopreserved embryos are not completely 
known. Achieving a live birth in the RCT 
could be one reason; 108/270 (40.0%) of the 
patients with a live birth in the RCT and 
43/47 (91.5%) of the patients with a 
multiple birth in the RCT had all their
surplus embryos destroyed. Some couples 
chose to continue with stimulated fresh 
cycles instead of frozen-thawed cycles.
However, the local policy at our clinic is to
use the cryopreserved embryos before 
 
 
 
Table 10. Characteristics of the additional frozen-thawed embryo transfers (FETs; after 
completion of the RCT). Numbers are expressed in mean±SD (range). Rates are 
expressed in % (no.). 
 
 
SET group DET group P
 (n=330) (n=331) 
 
 
Number of additional cryopreserved  
embryos 
 -total 848 873 0.37 
 -mean±SD (range) 2.57±2.64(0-15) 2.64±2.48(0-15)  
 
Number of embryos destroyed 
 -no (%) 344 (40.6%) 349 (40.0%) - 
 
Number of additional FETs 
 -total 233 189 0.61 
 -mean±SD (range) 0.71±0.98(0-4) 0.57±0.72(0-4) 
 
Number of embryos transferred per  
additional FET 1.35±0.44(1-3) 1.51±0.52(1-3) 0.011 
 
SET rate in additional FETs 66.5 (155/233) 51.9 (98/189) 0.003 
 
DET rate in additional FETs 32.2 (75/233) 46.0 (87/189) 0.005 
 
Triple embryo transfer rate in additional  
FETs 1.3 (3/233) 2.1 (4/189) 0.71 
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661 patients 
330: randomized 
to 1(+1) SET 
331: randomized 
to DET 
202:  no live birth 128:  achieved a 
live birth 
142: achieved a 
live birth 
 
 189: no live birth 
 RCT
27 achieved 
another live birth 
through additional
FETs 
17 achieved a live 
birth through 
additional FETs* 
17 achieved 
another live birth 
through additional
FETs 
27 achieved a live 
birth through 
additional FETs#
 
Additional
FETs 
CLBR (SET group) 
145/330 patients (44%)
CLBR (DET group) 
169/331 patients (51%)
Figure 17. Flow chart of the participants, with cumulative live birth rates.  
CLBR= cumulative live birth rate. 
*Two patients achieved two live births in the additional FETs. 
#One patient achieved two and one three live births in the additional FETs. 
proceeding with more fresh cycles. A 
spontaneous pregnancy could be a reason 
for not using the extra embryos in some
cases. It should also be born in mind that 
five years is quite a long time, and changes 
in life circumstances such as severe disease 
and divorce might also explain the waste of 
the extra embryos.
The number of embryos transferred in the 
additional frozen-thawed cycles was
unrelated to which randomization group the 
patient belonged to. One, two or in a few 
cases three embryos were transferred per 
frozen-thawed cycle, according to the 
patient’s wishes and routines at each IVF 
clinic (Table 10). The SET rate in the 
frozen-thawed cycles was, however, found 
to be significantly higher in the SET group 
than in the DET group, 66.5% and 51.9% 
respectively.  Also among the patients with 
no live birth in the RCT, there was a higher 
SET rate in the additional frozen-thawed 
cycles in the SET group (76.3%) than in the
DET group (50.0%). However, in some
cases the couple had no other choice than 
SET since they only had one cryopreserved 
embryo. This was true for 17.0% of the 
transfers in the SET group and 29.8% in the 
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DET-group. The reason the patients in the 
SET group chose more often SET in their 
frozen-thawed cycles is not clear, but may
reflect a psychological effect that couples 
who previously failed with SET are more
prone to accept one more SET than patients 
who previously failed with DET. 
Cumulative live birth rates 
The cumulative live birth rate, defined as 
the proportion of patients having achieved at 
least one live birth, was lower in the SET 
group (43.9%) than in the DET group 
(51.1%), but not significantly so (p=0.080, 
Table 11). The absolute difference in
cumulative live birth rates was 7.1% (95%
CI –0.5 to 14.7).  Some patients achieved 
more than one live birth, and the total
number of live births was 174 in the SET 
group and 189 in the DET group. Forty-
seven of the patients achieved two live 
births each, and one patient achieved three 
live births (Figure 17). Owing to the higher 
number of multiple births, the number of 
live born children was higher in the DET 
group (n=239), than in the SET group 
(n=178, p=0.009). The “implantation rate” 
expressed as the number of live born 
children per embryo transferred, was 0.22 in 
the SET group and 0.25 in the DET group 
(p=0.84). In the SET group there were 45 
miscarriages and three ectopic pregnancies.
In the DET group there were 40 
miscarriages and two ectopic pregnancies.
None of the differences in pregnancy 
outcome between the SET and DET groups 
was significant. 
A larger proportion of the patients in the 
original study with no live birth, 47.6%, as 
compared with the patients with a live birth,
39.6%, continued with additional frozen-
thawed transfers. Among the women who 
continued with additional frozen-thawed 
cycles, a smaller proportion of the patients 
who did not achieve a live birth in the
original study, 44/186 (23.7%), succeeded in 
achieving a live birth in the additional
frozen-thawed cycles as compared with the 
patients who achieved a live birth in the 
original study, 44/107 (41.1%, p=0.002).
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Figure 18. Cumulative live birth and multiple birth rates 
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Table 11: Cumulative live births and obstetric outcomes.  
 
 
SET group DET group P
 (n=330) (n=331) 
 
 
Cumulative live birth rates# 43.9 (145/330) 51.1 (169/331) 0.080 
 
Number of live births* 
 -total 174 189 0.20 
 -in the original study 128 142 0.28 
 -in the additional FETs 46 47 0.99 
 
Number of live born children 
 -total 178 239 0.009 
 -in the original study 129 189 0.016 
 -in the additional FETs 49 50 0.90 
 
Live born children per embryo transferred 
 -total 0.22 (178/825) 0.25 (239/944) 0.84 
 -in the original study 0.25 (129/511) 0.29 (189/660) 0.078 
 -in the additional FETs 0.16 (49/314) 0.18 (50/284) 0.73 
 
Multiple birth rates 
 -total 2.3 (4/174) 27.5 (52/189) <0.001 
 -in the original study 0.8 (1/128) 34.5 (49/142) <0.001 
 -in the additional FETs 6.5 (3/46) 6.4 (3/47) 1.00 
 
Preterm birth rates 
 -total 11.8 (21/178) 25.5 (61/239) <0.001 
 -in the original study 11.6 (15/129) 28.0 (53/189) <0.001 
 -in the additional FETs 12.2 (6/49) 16.0 (8/50) 0.81 
 
Very preterm birth rates 
 -total 2.2 (4/178) 5.9 (14/239) 0.11 
 -in the original study 2.3 (3/129) 7.4 (14/189) 0.076 
 -in the additional FETs 2.0 (1/49) - (0/50) 0.99 
 
Gestational age, days 
 -total 275.5±17.0 (200-298) 267.4±24.6 (168-304) 0.001 
 -in the original study 276.2±16.7 (200-298) 265.2±26.0 (168-304) <0.001 
 -in the additional FETs 273.9±17.9 (200-298) 275.7±16.0 (231-301) 0.58 
 
Rates are expressed as % (no), gestational age as mean±SD (range). 
FETs=frozen-thawed embryo transfers.  
#Number of patients with at least one live birth.  
*Some patients achieved more than one live birth. 
This may be an expression of a better 
prognosis in the group with than without a 
live birth in the original study.
Multiple births
The multiple birth rate was dramatically
lower in the SET group than in the DET 
group (Table 11, Figure 18). In the SET 
group there were four twin live births. In the 
DET group there were 48 twin live births 
and one triplet live birth. 
Obstetrical outcome 
The preterm birth rates (<37 gestational 
weeks) were significantly higher in the DET 
group, as a consequence of the higher 
multiple birth rates, than in the SET group 
(Table 11). Two intrauterine foetal deaths 
occurred. In three of the twin pregnancies in 
the DET group, one twin died in utero 
before gestational week 28. 
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General discussion 
Cumulative live birth rates
Cumulative live birth rates answer the
question of how great the chances are of a 
live birth after a series of IVF treatments,
the “take-home-baby-rate”.  In paper I the
cumulative live birth rates after three IVF 
cycles were presented. With the “realistic” 
estimate, 63% of the couples achieved a live 
birth after the three reimbursed fresh 
IVF/ICSI cycles, including the following
frozen-thawed transfers. The use of 
cumulative live birth rates instead of live 
birth rates per cycle provides the couple 
with a more accurate prognosis for 
achieving a live birth after IVF/ICSI
treatment. The patients in the study 
underwent their fresh IVF/ICSI cycles 
between 1996 and 2000. However, since the 
birth rates per cycle have remained about 
the same (annual results of 24.6% to 26.6% 
per fresh embryo transfer during 1996-2000, 
as compared with 27.3% in 2006 in Sweden, 
The Swedish National Board of Health and 
Welfare) despite the fact that the average
number of embryos transferred has 
decreased, the cumulative live birth rates 
presented in the study are probably also 
valid for the patients in treatment today. 
This is supported by the fact that a later
observational study from our centre 
including the patients’ first two fresh cycles 
with subsequent frozen-thawed transfers 
showed similar cumulative live birth rates as
in Paper I (Figure 19; Lundin and Bergh
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Figure 19. Cumulative live birth rates in Paper I as compared with a later published study 
from Sahlgrenska University Hospital (Lundin and Bergh 2007).  
*Cumulative live birth rates after cycles 1, 2 and 3, “conservative” estimates. 
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2007). The patients included in that study 
underwent their first fresh cycles during 
2003 and 2004. The majority of transfers in 
Paper I were DETs, while in Lundin and
Bergh the majority of transfers were SETs. 
In a recently published article from the
USA, the cumulative live birth rates after
three/six started cycles were 45%/51% in 
the conservative estimate and 53%/72% in
the optimistic estimate (life table analysis;
Malizia et al., 2009). However, in that study, 
frozen-thawed cycles were calculated as
separate cycles, in contrary to Paper I. In
another study, the cumulative pregnancy 
rates after three/four fresh started IVF 
cycles, without frozen-thawed cycles 
included, were 30%/31% in the conservative 
estimate and 45%/53% in the life table
analysis (same as the optimistic estimate;
Schroder et al., 2004). 
When comparing cumulative live birth
rates in different studies it is important to be 
aware of whether the results are presented
per completed cycle or, as in most other 
studies, per started cycle (Alsalili et al., 
1995; Engmann et al., 1999; Schroder et al., 
2004; Witsenburg et al., 2005; Malizia et al., 
2009). Other details to observe are whether 
the frozen-thawed cycles are calculated as 
separate cycles (Malizia et al., 2009), not 
included at all (Tan et al., 1992; Schroder et 
al., 2004) or included in the results of each 
fresh cycle (Paper I; Witsenburg et al., 
2005). The reason in Paper I for presenting 
the cumulative results of three completed
cycles or up to one live birth, and including 
the frozen-thawed cycles in each fresh 
cycle, was that the reimbursement system
allowed that number of treatments.
How many cycles are worth performing? 
In studies presenting cumulative
pregnancy/live birth rates for up to six 
consecutive cycles per woman, a steady
increase in the cumulative pregnancy/ live 
birth rates with each additional cycle has
been seen (Guzick et al., 1986; Alsalili et 
al., 1995, Schroder et al., 2004; Malizia et 
al., 2009). However, the live birth rate per 
cycle has been shown to decrease with each 
cycle, with the highest probability of a live
birth in the first cycle (Templeton et al., 
1996). In Paper I there was a decline in the 
live birth rates from 35.1% in the first cycle
to 26.7% in the third (p=0.02). The live birth 
rates in the fifth and sixth cycles in a recent
large study were 17.3% and 13.0% 
respectively, as compared with 24.5% in the 
first cycle (Malizia et al., 2009). The 
decrease in live birth rates with later cycles
is probably explained by the fact that the
patients with a good prognosis achieve a 
live birth before patients with poorer 
prognosis.
It can be concluded from the literature
that the cumulative live birth rates continue
to rise at least up to six cycles, however the 
chance of a live birth per cycle decreases
with each cycle.
Contribution to the cumulative live births
from the frozen-thawed cycles 
The frozen-thawed cycles provides an
important contribution to the cumulative
live births after IVF (see Introduction, p15). 
In Paper I, the contribution of the frozen-
thawed cycles to the live births was 20.0%. 
The frozen-thawed cycles are safer and 
more convenient for the woman since there 
is no need of ovarian stimulation, however
the live birth rates per embryo transfer are 
lower after frozen-thawed than after fresh
transfers (Table 2, introduction). A recent 
systematic review found better or as good 
obstetric outcome in children born after 
embryo cryopreservation, measured as 
56
preterm birth and low birth weight, when 
compared with children born after fresh 
embryo transfer. The neonatal data is mainly
based on slow freezing of cleavage stage 
embryos; there are few reports on neonatal 
outcome after slow freezing of blastocysts
and vitrification of cleavage-stage embryos, 
oocytes and blastocysts (Wennerholm et al., 
2009).
In Paper IV, 40.3% of all cryopreserved 
embryos were destroyed according to the 
patients’ own wish or because of the 
legislated time limit, and 33.1% of the 
patients had at least one cryopreserved 
embryo destroyed. A more efficient usage of 
the cryopreserved embryos would lead to 
improved cumulative live birth rates. 
Studies show that the couples’ decision-
making about what to do with surplus 
embryos is difficult and emotional. The 
decision-making is influenced by life
circumstances, embryo quality/quantity,
personal values, embryo conceptualization 
and clinic information. The decision-making
can be described in terms of a step-wise 
process; whether or not to use the embryos
for further conception attempts, whether or 
not to keep the embryos in cryopreservation, 
and whether or not to donate the embryos to 
other infertile couples or to research
(Nachtigall et al 2009; Provoost et al., 2009; 
however, embryo donation is currently not 
allowed in Sweden). The patients’
conceptualization of their frozen embryos
varies from seeing them in a medical-
technical way, to seeing them as genetic 
“insurances”, a symbol of the relationship or 
“virtual” children having interests that must
be considered and protected (Nachtigall et al
2005; Pravoost et al 2009). Studies suggest 
that patients can benefit from more
information about their alternatives, and 
opportunities to talk to others in similar
situations (Fuscaldo et al., 2007). In addition 
to this, a well-functioning cryopreservation 
program with a high survival rate of the 
thawed embryos and satisfactory live birth 
rates in frozen-thawed cycles is important.
Local policies at each clinic that encourages
the couples not to proceed with another 
fresh cycle before having used their frozen 
embryos, as well as patient information
about the advantages of cryopreservation 
cycles such as safety and convenience, 
might also contribute.
Paper III showed that high blastomere
survival rates, IVF compared to ICSI as 
fertilization method, and a high number of 
fresh cycles in the patient’s history were 
positive predictive factors for live birth in
frozen-thawed SET. The need to thaw a 
large number of embryos in order to achieve 
one transfer was a negative predictor for
pregnancy. That blastomere survival rate is 
a predictor for live birth/pregnancy in 
cryopreservation cycles has also been shown 
in several other studies (Guerif et al., 2002; 
Pal et al., 2004; Salumets et al., 2006; Tang 
et al., 2006; Edgar et al., 2007). The fact that 
IVF as fertilization method is a positive
predictor as compared with ICSI is in good 
accord with national Swedish (The Swedish 
National Board of health and welfare) and 
European results (Nyboe Andersen et al., 
2009) in both fresh and frozen-thawed 
cycles. The finding that the number of 
embryos thawed to obtain one transfer was a 
negative predictor of pregnancy has not to 
our knowledge been shown previously.  It is 
in accord with the theory of “cohort 
homogeneity”, i.e. that the embryos
originating from the same egg retrieval
(“egg cohort”) are of similar quality
(Trounson et al., 1986). The finding in other 
studies that previous pregnancy/live birth in 
cycles from the same egg retrieval are 
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positive predictive variables also supports
the theory of cohort homogeneity (El-
Toukhy et al., 2003; Urman et al., 2007). 
The reason a large number of fresh cycles in
the patient’s history was a positive predictor
of live birth is probably that the variable
included both failed and successful previous 
cycles. When only previous failed cycles
were studies, they were not found to impact
on the outcome. Other studies have shown 
that previous failed cycles were a negative
predicting variable (Thurin et al., 2005).
The newly introduced cryopreservation 
technique of vitrification has shown better 
survival rates after thawing for both
cleavage stage embryos and blastocysts as 
compared with slow freezing (Loutradi et 
al., 2008). There is at present no evidence of 
better clinical pregnancy rates after
vitrification as compared with slow freezing,
but the data published so far are limited
(Kolibianakis et al., 2009).
Improving the live birth rates; new 
techniques
Transfer of blastocyst stage embryos,
which are cultured to day 5/6, has been 
shown to result in higher live birth rates per 
couple than transfer of cleavage stage 
embryos, which are cultured to day 2/3, 
36.0% versus 29.4% in a Cochrane review
article (Blake et al., 2007).  However, in the 
blastocyst group as compared with the 
cleavage stage embryo group, there were 
fewer surplus embryos to cryopreserve, and 
failure to transfer any embryos at all was
more frequent (Blake et al., 2007). In the 
good prognosis group of patients, defined as 
having a high number of eight cell embryos
on day three, there was no difference in 
cycle cancellation rate and the authors 
concluded that single blastocyst transfer 
may be applicable in that patient group 
(Blake et al 2007). The delivery rates were 
similar after single cleavage-stage embryo
transfer including frozen-thawed cycles, and 
single blastocyst transfer including frozen-
thawed cycles, 34.2% and 37.9% 
respectively in an observational study 
(Guerif et al., 2009). Blastocyst culture is 
also being used increasingly after 
cryopreservation, i.e. embryos that were 
cryopreserved on day 2/3 can be cultivated
for another 2-3 days after thawing. This 
procedure might be an option for selecting 
an embryo with a high survival and 
implantation potential, especially for 
patients with a large number of cryopreser-
ved embryos.
Preimplantation genetic diagnosis (PGD)
is a laboratory technique where one or two 
cells from the embryo are biopsied and 
genetically analysed prior to transfer.
Preimplantation genetic screening (PGS) is 
a special type of PGD that has been used in 
conjunction with IVF in order to screen the 
embryos for aneuploidy, i.e. chromosomal
numerical errors. The purpose of such 
screening is to improve pregnancy and live 
birth rates, especially in women of advanced
maternal age. Even if a large number of 
observational studies have shown 
encouraging results after PGS, later random-
ized trials failed to confirm this. In fact, a 
meta-analysis concluded that PGS for 
aneuploidy was associated with lower rates 
of ongoing pregnancies and live births than 
standard IVF/ICSI without PGS (Checa et 
al., 2009). The explanation for this might be
that human embryos have a high rate of
mosaicism, leading to poor diagnostic
values when only one or two cells are 
examined (Baart et al., 2006). Another 
reason might be a detrimental effect of the
biopsy procedure itself on embryonic 
development (Hardarson et al., 2008). 
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It has been hypothesized that failure of
the blastocyst to implant could be caused by 
inability of the blastocyst to escape from the 
zona pellucida, a process called “hatching”.
Assisted hatching (AH), is a technique 
where a hole is made in the zona pellucida, 
chemically or by laser. A recent Cochrane 
review article showed an increased clinical
pregnancy rate and also a higher multiple
birth rate in patients randomised to AH as 
compared with controls (Das et al., 2009). 
The “omics” are a number of techniques
where the genomic constitution and/or the
metabolism of the embryo is analysed. It can 
be either invasive, when cells from the
embryo or blastocyst are biopsied and 
analysed for genetic markers (genomics), or 
non-invasive when proteins or metabolites
are analysed in the spent embryo culture
medium (proteomics, metabolomics).
Metabolomic and proteomic profiling of
human embryos have been shown in some
studies to correlate to implantation or live 
birth (Brison et al., 2004; Estes et al., 2008; 
Seli et al., 2009; Sturmey et al., 2009).
SET for preventing multiple births 
IVF and health aspects for the children 
The long-term impact on general health 
of the higher multiple birth rates and the 
higher preterm birth rates that have been a 
consequence of the increasing use of IVF, 
cannot be fully evaluated today, since only 
relatively few IVF children have reached 
adulthood. However, small size at birth has 
been found to be associated with 
cardiovascular disease and mortality in adult 
life, according to the Barker theory (Barker 
et al., 1995). A recent study on IVF children
of about twelve years of age showed 
significantly higher blood pressure and 
higher fasting glucose levels in the IVF
children as compared with age and gender 
matched controls who were offspring to 
subfertile couples. The differences could not 
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Figure 21. Contribution of ART to multiple births, singletons births and all births in 
Sweden 1995-2006 (data from The Swedish National Board of Health and Welfare). 
be explained by current body size, birth 
weight, early life factors, or parental 
characteristics such as cause of subfertility.
The subfertile couples and their controls 
were part of a large Dutch cohort, registered 
at IVF clinics between 1980 and 1995, 
where some received IVF treatment and 
some did not (Ceelen et al., 2008). Cerebral 
palsy was found to be 3.7 times more
common in IVF-children than in controls
(95% CI 2.0-6.6) and 2% of the IVF 
children as compared with 1% of the 
controls were in contact with a childhood 
disability centre in a Swedish population 
study (Strömberg et al., 2002). Although it 
can be concluded from the literature that 
IVF singletons also have an increased risk 
for adverse events and more research should 
be performed to find the reasons for that, a 
large share of the adverse events can be 
prevented by reducing the multiple birth 
rates.
As can be seen in Figure 20, the trend 
toward increasing multiple birth rates was 
broken in Sweden in 2003, and the 
contribution of IVF to all multiple births has
been decreasing since 2002 (Figure 21). 
This is in agreement with the major increase
in use of SET during the same time period. 
The Swedish National Board of Health and 
Welfare has presented annual reports on 
ART treatments since 1991, containing 
aggregated data. A Swedish nationwide 
Quality Registry for IVF, collecting data on 
all the IVF treatments on an individual level, 
was established in 2007 (data are reported 
on the web at http://www.ucr.uu.se/qivf).
This will enable cross-linkages with other 
population registries such as the Medical 
Birth Registry, the Cancer Registry, the
Healthcare Utilization Registry, the 
Malformation Registry and the Cause of 
Death Registry. Previous cross-linkages 
between the former IVF registry which, in
contrast to the new IVF registry contained 
data only on the IVF treatments resulting in 
a birth, and the population based registries 
have resulted in important knowledge, 
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particularly on safety aspects for the 
children (Bergh et al., 1999; Ericson and 
Källen, 2001; Ericson et al., 2002; Källen et 
al., 2005abc). 
Cumulative live birth rates after SET as
compared with DET 
The most important measure for 
decreasing high multiple birth rates is to
implement SET to a greater extent. SET has 
become increasingly implemented in
Sweden and some other Scandinavian and 
European countries during recent years. 
However, worldwide, SET cycles represent
a minority of all IVF cycles (see 
Introduction, Figure 6).
In Paper IV, the cumulative live birth 
rates after SET were not significantly lower 
than after DET in a randomized study 
population. The cumulative number of live 
born children was, however, higher in the 
DET group than in the SET group owing to 
a substantially higher multiple birth rate in
the DET group. A previously published 
Finnish randomized study, smaller than 
ours, reported cumulative live birth rates 
after only one fresh SET or one fresh DET 
including subsequent frozen-thawed cycles 
of 39% and 51% respectively, the difference 
not being significant. Most of the frozen-
thawed transfers in that study were, 
however, with two or more embryos
(Martikainen et al., 2001). A Dutch RCT 
with 404 patients included compared mild
stimulation protocol and SET, with 
conventional stimulation and DET. 
Cumulative live birth rates including frozen-
thawed transfers were 43.4% in the mild-
SET group and 44.7% in the conventional-
DET group, the difference was not 
statistically significant. The subsequent 
frozen-thawed transfers were either SET or
DET in both groups according to the 
patients’ preferences, in similarity to Paper
IV (Heijnen et al., 2007).
An observational study looking at the 
patients’ first two fresh cycles including 
subsequent frozen-thawed cycles showed 
similar cumulative live birth rates of 33.5%
and 32.3% after fresh DET and 34.8% and 
32.2% after fresh SET, although a larger 
number of frozen-thawed transfers were 
needed in the SET group (Lundin and 
Bergh, 2007). A study comparing success 
rates from a time period with a higher rate
of DET to a time period with a wider use of 
elective SET, showed significantly higher 
cumulative live birth rates in the SET period 
than in the DET period, 41.7% versus 36.6% 
(Veleva et al., 2009). Interestingly, the risks 
of low birth weight and preterm birth have 
been shown to be significantly higher after 
DET than SET when comparing only
singletons (De Sutter et al., 2006). In a 
systematic review comparing SET with 
DET from a cost-effectiveness point of 
view, taking into account total cost per live
birth, a health care perspective and a societal 
perspective, it was concluded that elective
SET may be preferable to DET in patients
with a good prognosis and when frozen-
thawed cycles are included (Fiddelers et al.,
2007).
In conclusion, the live birth rate per fresh 
transfer is higher after DET than SET, 
whereas the cumulative live birth rates when 
including subsequent frozen-thawed trans-
fers have not shown to differ significantly in 
three RCTs. There were, however, 
numerically higher cumulative live birth
rates in the DET group in two of the RCTs
(Martikainen et al., 2001; Paper IV), not 
reaching statistical significance.
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“Mild” IVF 
The decrease in the number of embryos
transferred per cycle that has taken place 
over the last decade has led to a growing 
interest in milder ovarian stimulation
protocols, with the aim of creating a safer,
more patient-friendly and cost-effective
regimen. The mild stimulation protocols 
often include low-dose gonadotropin 
administration combined with GnRH 
antagonist later during the stimulation, in 
contrast to the conventional long stimulation 
protocol with initial GnRH-agonist and
higher dosages of gonadotropins (Verberg et 
al., 2009). The mild stimulation result in 
fewer mature oocytes per cycle, but is 
considered to have the advantages of a 
lower risk of ovarian hyperstimulation 
syndrome (OHSS), lower costs, lower 
dropout rates, and possibly less patient 
discomfort (Heijnen et al., 2007; Verberg et 
al., 2008a; Aboulgar 2009). One interesting 
finding was the occurrence of less embryo
aneuploidy following mild stimulation than 
after conventional stimulation (Baart et al., 
2007).
A randomized non-inferiority trial 
compared mild stimulation combined with
SET with conventional stimulation 
combined with DET, in a cohort of women
under 38 years of age (Heijnen et al., 2007). 
The cumulative live birth rates after one 
year were similar in both groups (see 
previous page), but there was a significantly 
lower multiple birth rate (0.5% versus 
13.1%) in the mild SET group as compared
with the conventional DET group. Although 
there was a larger number of started cycles 
in the mild stimulation group (mean 2.3 
versus 1.7, p<0.0001), owing to a higher 
cancellation rate the number of embryo
transfers per group was similar (mean 1.5 
versus 1.4, p=0.5). The levels of patient 
discomfort were approximately the same in 
the two groups (Heijnen et al., 2007). A 
cost-effectiveness analysis on these patients
showed lower costs over a 12 months period 
for the mild SET group than the 
conventional DET group, mainly due to 
higher obstetric and postnatal costs 
connected to the multiple births in the latter
group (Polinder et al., 2008). 
A milder stimulation protocol yields 
fewer embryos per cycle for cryopreser-
vation, which could lead to lower 
cumulative live birth rates. However, in
Paper IV a large number of the cryopreser-
ved embryos were not used by the patients, 
an important observation that needs further 
analysis.
It seems reasonable to change the ovarian 
stimulation protocols in a milder and safer 
direction, producing somewhat fewer 
embryos per cycle than today but with the 
advantage of less discomfort for the patient 
and a lower risk of OHSS. However, to 
evaluate milder stimulation per se, both for 
efficacy and safety, well designed RCTs are 
needed.
Patients’ experiences of IVF treatment 
Many IVF-patients, not surprisingly, 
perceive the treatment as emotionally
stressful, particularly when they do not 
succeed in achieving a live birth (Holter et 
al., 2006; Verhaak et al., 2007). Couples
entering IVF treatment have, however, been 
shown to be in general psychologically well 
adjusted (Eugster et al., 1999). 
The infertility problem encompasses
many aspects of life: male/female identity,
existential questions and societal pressure.
These can be difficult issues to deal with. 
However, encouraging results were shown 
in a Chinese small follow-up study of 
couples that had experienced unsuccessful
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IVF treatment. Some remained childless,
some had adopted, and some had conceived 
naturally. The women and men in the study 
all reported valuable gains through 
experiencing their infertility problem: on a 
personal level, in their relationships, and in 
some cases also spiritual growth (Lee et al.,
2009). Another study that assessed men and 
women before, during and 6 months after 
infertility treatment found more discourag-
ing data: after unsuccessful treatment the
women showed increased anxiety and 
depression, and at follow-up, >20% of the 
women showed remaining subclinical forms
of anxiety and/or depression. Personality 
characteristics, meaning of the fertility
problems, and social support determined the
course of psychological response. The men
in the study showed no significant changes 
in anxiety or depression levels (Verhaak et 
al., 2005). The marital relationship has been 
reported in several studies to either be 
strengthened during the infertility treatment
or not affected at all (Sydsjö et al., 2005; 
Holter et al., 2006). In a Swedish study on 
gender differences in psychological 
reactions to infertility, the women reacted
more strongly to the infertility problem than 
the men, and the most important factor for 
the women of having children was 
summarized as “the major focus of life”. 
The most important factor for the men of 
having children was “The male role and 
social pressure” (Hjelmstedt et al., 1999).
What the patients experience as most
stressful during the treatment, besides an
unsuccessful treatment, is the waiting time
after embryo transfer until the pregnancy 
test (Eugster et al., 1999). After successful 
IVF treatments, IVF patients experience
more stress during pregnancy than parents 
who conceived spontaneously (Eugster et 
al., 1999). Mothers of IVF children have 
been shown to experience a higher quality in 
the parent-child relationship than mothers 
who naturally conceived (Eugster et al., 
1999). In studies on coping behaviour in 
IVF couples, avoidance behaviour (e.g. 
avoiding being with pregnant women or
children, working to take one’s mind off
things) and accepting responsibility (e.g. 
criticizing one-self, feeling responsible for 
having brought the problem on oneself) 
were related to increased infertility stress.
Seeking social support, problem solving, 
distancing and meaning-based coping (e.g. 
trying to find a meaning in what is 
happening) were related to less infertility
stress (Schmidt et al., 2005; Peterson et al., 
2006; Peterson et al., 2009). 
Do psychological factors affect the live
birth rates?
The questions of whether stress, 
depression, anxiety and other psychological 
factors have negative impacts on the live 
birth rates, and whether psychological 
interventions can improve live birth rates, 
have been matters for a great deal of 
research. No scientific consensus has been 
reached, and there are plenty of contradict-
ing studies. Although two systematic
reviews found no evidence for a relation
between psychological stress and decreased 
pregnancy rates, the studies in this field are 
heterogeneous and difficult to compare
(Klonoff-Cohen et al., 2005; Homan et al., 
2007).
A study conducted at our centre showed 
no association between psychological well-
being before treatment measured using 
questionnaires and the chance of pregnancy 
(Anderheim et al., 2005). In another study 
from our centre, the patients were offered 
extended encounters with a midwife before, 
during and after the treatment, at which the
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patients were encouraged to talk about their 
feelings and what was important to them.
The extended encounters did not result in 
any significant effects on the patients’ well-
being or on the pregnancy rates. However, 
the patients who did not achieve a 
pregnancy and who had extended midwife
encounters expressed greater satisfaction 
with the care than the controls (Anderheim
et al., 2007).
In a systematic review of the effects of 
psychosocial interventions in infertility
treatment, pregnancy rates were not found to 
be affected by the interventions. In terms of 
increase the psychological well-being, group 
interventions that emphasized training and 
skills (e.g. relaxation training) were more
effective than interventions that emphasized
emotional expression (e.g. discussing 
feelings and thoughts, Boivin, 2003).
Reasons for discontinuing IVF treatment 
An unexpectedly high proportion of the 
couples in Paper I discontinued their IVF
treatment, 54% of all couples who did not 
achieve a live birth. A small group (3.1%) 
had only cancelled cycles and performed no 
embryo transfers at all. The dropout rates for 
patients who did not achieve a live birth 
after the first and second completed cycles
were 19.9% and 39.0%, respectively. 
Similar or higher dropout rates have been 
reported in other studies.  In a study from 
Germany, where the insurance companies 
cover the cost of the first four treatments, it 
was shown that 39.3% of the non-pregnant 
patients dropped out after one started cycle 
and 44.1% after two started cycles 
(Schroder et al., 2004). In a Dutch study 
where there is a similar reimbursement
system as in Sweden, 43% of the patients 
dropped out following the first cycle and 
57% following the second cycle (Verberg et 
al., 2008a). In a British study, with a high 
rate of self-funded patients, there was a 
dropout rate after one cycle of 58.5% 
(Sharma et al., 2002).
The most frequently reported reasons for 
discontinuing treatment given in Paper II 
were psychological stress (26%) and poor 
prognosis (25%). A recent Dutch study on 
reasons for dropout showed similar results 
(Verberg et al., 2008a). Physical and 
psychological factors were the most
important reasons (28%). This study also 
showed that mild stimulation can result in
lower dropout rates (Verberg et al., 2008a). 
In a British study, psychological stress was 
cited as reason for dropping out by 36% of 
the patients, and lack of success by 23%; 
these two reasons were strongly correlated 
(Rajkhowa et al., 2006). The fact that 
treatment was not reimbursed was stated by 
23% of the patients as the reason for 
dropping out, and changes in personal 
circumstances by 30% (Rajkhowa et al., 
2006). Pre-treatment psychological 
characteristics were related to the dropout 
rate in the group who stopped for 
psychological reasons in one study (Smeenk
et al., 2004), while another study found no 
influence on the dropout rates of pre-
existing anxiety or depression (Lintsen et 
al., 2009). In-depth interviews with women
who decided to drop out showed that the 
women felt they had started treatment with 
unrealistic expectations. The women felt
vulnerable to the pressures from society and 
media. Although the decision to cease IVF 
treatment was a way out of the distress it 
also led to a sense of confrontation with 
issues they had previously avoided. Couples 
who had adopted a child reported feeling 
less societal pressure than those who 
remained childless (Peddie et al., 2005). 
Several studies have shown correlations 
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between poor prognosis and dropping out of 
treatment (Sharma et al., 2002, Malizia et 
al., 2009), but some studies have also shown 
no difference in prognostic factors among
those who continued and those who dropped 
out (De Vries et al., 1999).
What can be done to lower the dropout 
rates?
In countries with no reimbursement
system covering infertility treatments, lack
of funding is an important reason for not
continuing treatment (Rajkhowa et al., 
2006). In these countries, subsidized IVF 
treatment would be an important political
step in order to increase nativity rates.
A considerable proportion of the patients
in Paper II reported organizational 
shortcomings: “never the same people from 
one appointment to the next”, “stressful 
assembly-line treatment”, “we needed more
information on treatment and alternatives”.
Taking these comments into consideration, 
organizational and educational improve-
ments can be made to create a more
“patient-friendly” environment at IVF 
clinics. A recent American article on
dropout reasons among insured patients, 
showed that stress was the most important
factor, and the top-rated suggestions from 
the patients for patient support, were written 
information on how to deal with 
psychological stress and easy access to a 
psychologist or social worker (Domar et al., 
2009).
In summary, IVF treatment is often 
experienced as emotionally demanding for 
the patients. There is no evidence of a 
negative effect of psychological stress on 
the live birth rates. Supporting the couples 
to cope with infertility-related stress is not
only valuable to their well-being, but might
also decrease the dropout rates, which in
turn could lead to improved cumulative live 
birth rates. 
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Conclusions
The following conclusions can be drawn from this thesis: 
- There is a good chance of achieving a live birth through a treatment programme of three 
fresh IVF/ICSI cycles including subsequent frozen-thawed cycles. The cumulative live birth
rates after one fresh SET including subsequent frozen-thawed cycles was not significantly
lower than after DET, in a randomized patient population. The advantage of SET is the 
dramatically reduced multiple birth rate.
- Frozen-thawed embryo transfers constitute an important contribution to the cumulative
live births. The knowledge of which factors are predictive for live birth in frozen-thawed 
cycles is of value when deciding whether to perform SET or DET in frozen-thawed cycles.
- A large proportion of the patients discontinued the treatment programme before
achieving a live birth. The most common reasons were psychological stress and poor 
prognosis. A frequent comment in the questionnaires was the need of more information about 
the treatment. The knowledge that many patients perceive IVF treatment as emotionally
demanding and feel a need of more information can be useful in patient consultations and 
when organizing care at the clinics. 
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